Introduction {#s1}
============

Microglia are critically important for normal brain development in the embryonic and early postnatal stages ([@bib25]). Originally thought to be primarily involved in injury and disease, many recent studies have implicated microglia in diverse neurodevelopmental functions ([@bib65]; [@bib57]; [@bib73]; [@bib27]). However, much less is known about what role microglia might play in the healthy adult brain, even during the process of adult neurogenesis, which can be thought of as an extension of developmental processes throughout the lifespan.

During early postnatal development, microglia have been implicated in the regulation of synaptic development, including activity-dependent synaptic pruning ([@bib62]; [@bib59]; [@bib64]; [@bib48]; [@bib23]) on one hand and promotion of synaptic development and maturation on the other ([@bib28]; [@bib74]; [@bib41]; [@bib44]). Although microglia seem well-positioned to perform similar roles to facilitate the integration of adult-born neurons into circuits in the adult brain in the dentate gyrus (DG) and olfactory bulb (OB) ([@bib20]; [@bib55]), most studies on microglial regulation of adult neurogenesis to date have focused on early stages of the process occurring in the neurogenic niches. For example, hippocampal adult neurogenesis is impaired in models of neuroinflammation ([@bib43]; [@bib19]) and in immune-deficient mice ([@bib75]). Microglia regulate adult neurogenesis in the subgranular zone of the DG through ongoing phagocytosis of apoptotic neuroblasts ([@bib60]), although they do not seem to be similarly involved in the subventricular zone (SVZ) or rostral migratory stream (RMS) ([@bib33]; but see [@bib54] for counterevidence).

Most of what is known about microglial involvement in later stages of neurogenesis is based on injury and disease models. Microglial activation via sensory deafferentation in the OB decreases the number of adult-born neurons ([@bib34]) and their spine density ([@bib12]). In addition, lipopolysaccharide injection or CX3CR1 knockout activates microglia in the hippocampus and alters both inhibitory ([@bib29]) and excitatory ([@bib5]) synapses onto adult-born neurons in the DG. These studies suggest that microglia can modulate the synaptic integration of adult-born neurons under inflammatory conditions, but raise the question of whether they are similarly involved in the healthy adult brain.

A recent study documented increased activity in principal neurons in the OB after microglial depletion ([@bib53]). Here we investigate the cellular and circuit mechanisms behind this effect by analyzing the functional development of adult-born granule cells (abGCs) in the absence of microglia. We demonstrate that microglial depletion during, but not after abGC development reduces activity in abGCs that make inhibitory connections with principal cells in the OB. We show that microglia normally interact with spines in developing abGCs, and the volume of these spines is reduced when microglia are ablated. This is accompanied by a reduction in the amplitude of excitatory but not inhibitory inputs to abGCs, suggesting that microglia are essential for proper integration of abGCs in adult circuits.

Results {#s2}
=======

Microglia preferentially interact with spines on abGCs {#s2-1}
------------------------------------------------------

We labeled cohorts of abGCs born using lentiviral injection into the RMS ([@bib11]; [@bib39]) of adult 8--12 week old mice. To visualize interactions between microglia and abGCs, we performed time-lapse in vivo two-photon imaging of the dendrites of dTomato-labeled abGCs in the external plexiform layer (EPL) of the OB over the first four weeks after injection in CX3CR1-GFP +/- mice, in which microglia are labeled with GFP ([Video 1](#video1){ref-type="video"}, [Figure 1A](#fig1){ref-type="fig"}). Consistent with previous observations ([@bib45]; [@bib64]), we found that microglial processes were highly motile and occasionally appeared in close proximity to labeled dendritic spines ([Video 2](#video2){ref-type="video"}, [Figure 1B](#fig1){ref-type="fig"}). To quantify whether microglia preferentially interact with dendritic spines (defined as colocalization of a microglial process with at least 5% of the area of a spine head, see Materials and methods, *Analysis of microglia-spine interactions*) on abGCs compared to encountering them by chance during the course of continuous motility, we compared the frequency of interactions between microglial processes and spine heads in the actual imaging data with the frequency of interactions in a series of images in which the microglia channel was arbitrarily shifted with respect to the dendritic imaging channel ('Offsets').

![Microglia preferentially interact with mushroom spines on developing abGCs.\
(**A**) Maximum intensity projection (10 µm volume at the first imaging timepoint) showing dTomato-labeled abGCs in a CX3CR1-GFP heterozygous mouse imaged 4 weeks after lentivirus injection. Brightness and contrast adjusted for display only. (**B**) Single plane time series showing the region marked in (**A**). Inset shows the calculated percent microglial coverage for the spine marked with the arrowhead (images shown for six frames, 7^th^ frame not shown but the value is plotted, showing the end of the interaction) with the larger circle marking the value for the corresponding frame. Brightness and contrast adjusted with the same parameters for each timepoint for display only. (**C**) Single plane image showing an example of a spine classified as a mushroom spine because the spine head is wider and brighter than the spine neck. (**D**) Probability distribution showing the proportion of mushroom spines with at least one microglial interaction for mushroom spines in the real data (black line, 'Data') compared to values calculated from iteratively translating the microglial channel relative to the dendritic imaging channel (gray histogram, 'Offsets'). The proportion of spines with interactions was not significantly higher than chance (one-tailed permutation test, p=0.13). (**E**) Probability distribution showing the number of interactions (normalized to 10 min) for mushroom spines. The mean number of interactions (value for each dendrite is the mean number across all mushroom spines on that dendrite) in the real data was significantly higher than chance (one-tailed permutation test, p=0.048). (**F**) Probability distribution showing interaction length for mushroom spines (for spines that had at least one frame that met the criteria for an interaction, see Materials and methods). The mean interaction length across all dendrites (value for each dendrite is the mean interaction length across all interactions for all mushroom spines) was not higher than chance (one-tailed permutation test, p=0.96). (**G**) Probability distribution showing maximum percent coverage (mean across all interactions for a given spine for spines that had at least one frame that met the criteria for an interaction). The mean maximum percent coverage across all dendrites (value for each dendrite is the mean interaction length across all interactions for all mushroom spines) was not higher in the real data (one-tailed permutation test, p=0.72). (**H**) Single plane image of a spine classified as a filopodial spine because it has no clear spine head. (**I**) Probability distribution showing the proportion of spines with at least one microglial interaction for filopodial spines. The proportion of filopodial spines with interactions was not significantly higher than chance (one-tailed permutation test, p=0.39). (**J**) Probability distribution showing the number of interactions (normalized to 10 min) for filopodial spines. The mean number of interactions (value for each dendrite is the mean number across all filopodial spines on that dendrite) in the real data was not significantly higher than chance (one-tailed permutation test, p=0.72). (**K**) Probability distribution showing interaction length for filopodial spines (for spines that had at least one frame that met the criteria for an interaction, see Materials and methods). The mean interaction length across all dendrites (value for each dendrite is the mean interaction length across all interactions for all filopodial spines) was not significantly higher than chance (one-tailed permutation test, p=0.23). (**L**) Probability distribution showing maximum percent coverage (mean across all interactions for a given spine for spines that had at least one frame that met the criteria for an interaction). The mean maximum percent coverage across all dendrites (value for each dendrite is the mean interaction length across all interactions for all filopodial spines) was not higher in the real data (one-tailed permutation test, p=0.84). n = 726 spines (271 mushroom spines and 455 filopodial spines) from 48 dendrites combined at 1, 2, 3, and 4 weeks post injection in three mice. ns, not significant; \*p\<0.05.\
Figure 1---source data 1.This spreadsheet contains the values used to create the histograms in [Figure 1D--G and I--L](#fig1){ref-type="fig"}.](elife-50531-fig1){#fig1}

###### Z stack showing microglia and abGC dendrites.

The movie shows the entire field of view at the beginning of the imaging session for the example shown in [Figure 1](#fig1){ref-type="fig"}. The z stack volume spans 29 µm and was taken at 32 dpi. The analysis in [Figure 1](#fig1){ref-type="fig"} was performed on individual planes from such z stacks.

###### Time series showing interactions between microglia and dendritic spines of abGCs.

The movie shows a single plane taken from the z stack in [Video 1](#video1){ref-type="video"} across 48 min of imaging (images taken 3 min apart). The time course of the interaction between a microglial process and the mushroom spine shown in the example in [Figure 1](#fig1){ref-type="fig"} can be observed. The analysis in [Figure 1](#fig1){ref-type="fig"} was performed on individual planes from such time series.

Microglia exhibited an impressive degree of motility, interacting with 38.5% of abGC dendritic spines classified as 'mushroom' spines ([Figure 1C](#fig1){ref-type="fig"}) and 27.2% of spines classified as 'filopodial' spines ([Figure 1H](#fig1){ref-type="fig"}) during the course of our 30--90 min imaging sessions, which was not significantly different from the offset data (p=0.13 and p=0.39, respectively) ([Figure 1D,I](#fig1){ref-type="fig"}). However, we found that microglia interacted significantly more often with individual mushroom spines than predicted by chance (Data: mean 0.15 ± 0.00039 interactions/10 min vs. Offsets: mean 0.12 ± 0.016 interactions/10 min, p=0.048) ([Figure 1E](#fig1){ref-type="fig"}) though the length of individual interactions was not significantly greater(p=0.96) ([Figure 1F](#fig1){ref-type="fig"}). In contrast, microglia did not interact with filopodial spines at levels above chance ([Figure 1I--L](#fig1){ref-type="fig"}). Microglia did not cover significantly more of the spine than predicted by chance during interactions with either spine type (Mushroom: p=0.72, Filopodial: p=0.84) ([Figure 1G,L](#fig1){ref-type="fig"}).

These results suggest that microglia specifically interact with spines that likely contain functional synapses ([@bib69]), positioning them to influence synaptic stabilization and maturation during the early development of abGCs.

Odor responses are reduced in abGCs that mature in the absence of microglia {#s2-2}
---------------------------------------------------------------------------

To assess whether microglial functions are essential for the development of abGCs, we ablated microglia during the entire time course of abGC development, beginning three weeks before lentiviral labeling ([Figure 2A](#fig2){ref-type="fig"}). Microglial depletion using the CSF1R inhibitor PLX5622 (hereafter PLX) formulated in chow as previously described ([@bib21]) efficiently ablated microglia from the OB (85% ablation as assessed by immunostaining, 96% ablation as assessed by flow cytometry) within one week and depletion could be maintained at similar levels for up to nine weeks with ongoing delivery ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplements 1](#fig2s1){ref-type="fig"} and [2](#fig2s2){ref-type="fig"}). We found no evidence of any largescale inflammatory response to microglial depletion, as assessed by immunostaining of glial fibrillary acidic protein (GFAP) ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}), consistent with previous reports of the effects of PLX on the whole brain ([@bib21]) and the olfactory bulb ([@bib53]).

![Microglial depletion during development reduces odor-evoked responses of abGCs in anesthetized mice.\
(**A**) Experimental timeline for microglial depletion during development of abGCs. A cranial window was implanted and 3 weeks later mice were given control or PLX5622-containing chow for the remainder of the experiment. After 3 weeks of chow consumption, a lentivirus was injected into the RMS to label abGCs, which were imaged 5--6 weeks later. (**B**) Left, images of Iba1 staining in the olfactory bulb of control (top) and PLX-treated (bottom) mice. White squares show the locations of the enlarged insets. Dotted lines mark the upper edge of the glomerular and granule cell layers. Right, schematic showing injection of a lentivirus encoding dTomato and GCaMP6s and microglial depletion. (**C**) Example fields of view showing an average intensity projection of dTomato structural images of abGC dendrites (left) and overlaid heatmaps of GCaMP6s-recorded activity (right) in response to ethyl valerate in control (top) and PLX5622-treated (bottom) mice. (**D**) GCaMP6s traces showing odor responses of example ROIs from control (top) and PLX-treated (bottom) mice (chosen to have the same ranked response to the first odor). Gray traces represent responses on individual trials and colored trace is the mean across trials. Individual trial traces were median filtered over three frames before averaging for presentation. \*, odor responses for which the mean response was above threshold (**E**) Heatmap traces from the 100 ROIs with the largest odor-evoked Ca2+ signals across all mice ranked separately for each of 15 odors (molecular structures shown above). Black bar denotes odor time. Bottom, mean response time course for each odor across all ROIs. (**F**) Cumulative distribution showing that the distribution of responses (averaged across odors for each dendrite) is shifted to the left in PLX-treated mice (Two sample Kolmogorov--Smirnov test for probability distributions, D = 0.25, p=2.56e-08) while the noise distributions constructed from blank trials are not different (D = 0.042, p=0.96). (**G**) Cumulative distribution showing the number of effective odors (odors that evoked responses above the ROC threshold 0.39, which was calculated across all dendrites from both groups). The median number of effective odors was significantly lower in the PLX-treated group (Wilcoxon rank sum test, z = 3.86, p=1.15e-04). (**H**) Raincloud plot showing the distribution of lifetime sparseness across all dendrites. Above, kernel density estimate. Below, boxplot showing the median, interquartile range (box), and 1.5 times the interquartile range (whiskers) superimposed on a dot plot of all the data (one dot per dendrite). Median lifetime sparseness was significantly lower in the PLX-treated group (Wilcoxon rank sum test, z = 3.53, p=4.18e-04). n = 287 dendrites from five control mice and 277 dendrites from 7 PLX-treated mice. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001.\
Figure 2---source data 1.This spreadsheet contains values from each dendrite from each mouse for [Figure 2F,G and H](#fig2){ref-type="fig"}.](elife-50531-fig2){#fig2}

At five to six weeks post injection, when abGCs have reached a functionally mature state ([@bib67]), we used two-photon imaging to visualize abGC dendrites in vivo. Microglial depletion did not affect the overall number of adult-born neurons in the OB ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}), consistent with other reports, ([@bib53]; [@bib33]), and we could readily identify dTomato-labeled abGC dendrites in control and PLX-treated mice. Since GCs in the OB are axonless and their release sites are located at dendodendritic synapses on spines in the EPL ([@bib52]), we chose to record calcium responses in these dendrites. We first recorded responses in anesthetized mice to a panel of 15 monomolecular odors (Materials and methods, *Odor stimulation*, [Table 1](#table1){ref-type="table"}), while simultaneously imaging morphology in the dTomato channel to aid in region of interest identification and image alignment ([Figure 2C](#fig2){ref-type="fig"}). AbGC responses to odors were sparse as previously described ([Figure 2D](#fig2){ref-type="fig"}; [@bib67]), but across the population we could identify dendrites responding to most of the odors in our panel ([Figure 2E](#fig2){ref-type="fig"}). We characterized responses by taking the mean ΔF/F~σ~ value over a five-second period following the onset of a two-second odor stimulus and plotted the cumulative distribution of dendritic responses across all odors. The distribution was shifted left toward lower responsiveness in PLX-treated mice (p=2.56e-08) while the noise distributions constructed from blank trials were not different (p=0.96) ([Figure 2F](#fig2){ref-type="fig"}). Dendrites in PLX-treated mice also responded to fewer odors (for threshold response criteria, see Materials and methods, In vivo imaging analysis, Thresholds) (median (IQR): Control: 3 (1--6), PLX: 1 (0--4), p=1.16e-04) ([Figure 2G](#fig2){ref-type="fig"}). We also found that lifetime sparseness ([@bib72]), (bounded between 0 and 1, a low score indicates a sparser representation) was lower in dendrites in PLX-treated mice (median (IQR): Control: 0.18 (0.067--0.32), PLX: 0.067 (0--0.25), p=4.18e-04) ([Figure 2H](#fig2){ref-type="fig"}). These effects were also significant when we performed hierarchical bootstrapping ([@bib58]) to take into account the fact that we imaged dozens of dendrites from each mouse, with dendrites in PLX-treated mice responding to fewer odors (mean Control: 3.6 ± 0.38, PLX: 2.8 ± 0.26, p=0.050) ([Figure 2---figure supplement 5B](#fig2s5){ref-type="fig"}) and having lower median response amplitudes (median Control: 0.14 ± 0.039, PLX: 0.070 ± 0.016, p=0.0011) ([Figure 2---figure supplement 5D](#fig2s5){ref-type="fig"}). However, there was no difference in the median amplitude of responses above threshold (p=0.77) ([Figure 2---figure supplement 5F](#fig2s5){ref-type="fig"}), suggesting that the difference in overall responses was mostly mediated by an increase in the proportion of dendrites that did not respond to any of the odors in our panel, which was significantly higher in PLX-treated mice (Control: 0.14 ± 0.039, PLX: 0.32 ± 0.039, p=0.0013) ([Figure 2---figure supplement 5E](#fig2s5){ref-type="fig"}).

###### Common names and chemical structures for monomolecular odor stimuli.

  ------------------- ----------------------------- ------------------ ----------------------------
  Ethyl tiglate       ![](elife-50531-inf1.jpg)     Valeraldehyde      ![](elife-50531-inf2.jpg)

  Ethyl valerate      ![](elife-50531-inf3.jpg)     Isoamyl acetate    ![](elife-50531-inf4.jpg)

  Valeric acid        ![](elife-50531-inf5.jpg)     Anisole            ![](elife-50531-inf6.jpg)\

  Allyl butyrate      ![](elife-50531-inf7.jpg)     Ethyl propionate   ![](elife-50531-inf8.jpg)

  Carvone             ![](elife-50531-inf9.jpg)     Propyl acetate     ![](elife-50531-inf10.jpg)

  2-methoxypyrazine   ![](elife-50531-inf11.jpg)\   2-heptanone        ![](elife-50531-inf12.jpg)

  Isoeugenol          ![](elife-50531-inf13.jpg)    Acetophenone       ![](elife-50531-inf14.jpg)

  Allyl tiglate       ![](elife-50531-inf15.jpg)                       
  ------------------- ----------------------------- ------------------ ----------------------------

While imaging in anesthetized mice allows better control of breathing rate, brain motion, and possible motivational influences on brain state, granule cell odor representation is significantly different in awake mice ([@bib31]; [@bib71]; [@bib67]). Therefore, we also imaged abGC dendrites in awake mice and found similar effects as in anesthetized mice ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Dendrites in PLX-treated mice had lower responsiveness (p=0.037) ([Figure 3B](#fig3){ref-type="fig"}), responding to a lower median number of odors (median (IQR) Control: 1 (0--6), PLX: 0 (0--3), p=0.052) ([Figure 3C](#fig3){ref-type="fig"}) and having lower lifetime sparseness (median (IQR) Control: 0.067 (0--0.28), PLX: 0 (0--0.16), p=0.056) ([Figure 3D](#fig3){ref-type="fig"}). Interestingly, while response time courses were similar between control and PLX-treated mice in the anesthetized state (p=0.30), allowing us to characterize responses with a simple mean across the odor analysis period, principal components analysis of the ΔF/F~σ~ traces for all cells' responses to all odors revealed different response time courses in awake mice (p=0.004) ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). These differences were likely not due to changes in active sampling of odors since sniffing rates were not different during baseline or odor presentation periods (mean Baseline: Control = 3.49 Hz, PLX = 3.52 Hz, p=0.91; Odor: Control = 4.00 Hz, PLX = 3.94 Hz, p=0.81) ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). To ensure that our analysis of response amplitudes was not complicated by this possible change in response timing, we also applied an event detection analysis method (using a sliding window across the response period to detect increases in fluorescence above a noise threshold, see Materials and methods, In vivo Imaging analysis, Event detection) to the awake data and found similar results with dendrites in PLX mice still characterized by responses to a lower median number of odors (p=0.037) ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

![Microglial depletion during development reduces odor-evoked responses of abGCs in awake mice.\
(**A**) Above, Heatmap traces from the 100 ROIs with the largest odor-evoked Ca2+ signals across all mice ranked for each of 15 odors (molecular structures shown above). Below, Mean response time course for each odor across all ROIs. Black bar denotes odor time. (**B**) Cumulative distribution showing that the distribution of responses (averaged across odors for each dendrite) is shifted to the left in PLX-treated mice (Two sample Kolmogorov--Smirnov test for probability distributions, D = 0.18, p=0.037) while the noise distributions constructed from blank trials are not different (D = 0.11, p=0.45). (**C**) Cumulative distribution showing the number of effective odors (odors that evoked responses above the ROC threshold 0.52, which was calculated across all dendrites from both groups). There was a trend toward a lower median number of effective odors in the PLX-treated group (Wilcoxon rank sum test, z = 1.95, p=0.052). (**D**) Raincloud plot showing the distribution of lifetime sparseness across all dendrite. Above, kernel density estimate. Below, boxplot showing the median, interquartile range (box), and 1.5 times the interquartile range (whiskers) superimposed on a dot plot of all the data (one dot per dendrite). There was a trend toward lower median lifetime sparseness in the PLX-treated group (Wilcoxon rank sum test, z = 1.91, p=0.056). n = 105 dendrites from three control mice and 132 dendrites from 4 PLX-treated mice. \*p\<0.05.\
Figure 3---source data 1.This spreadsheet contains values from each dendrite for [Figure 3B,C and D](#fig3){ref-type="fig"}.](elife-50531-fig3){#fig3}

Microglial depletion after abGC development has no effect on odor responses {#s2-3}
---------------------------------------------------------------------------

We next wondered whether the effect of microglial depletion was specific to abGCs developing in the absence of microglia or whether it might affect abGCs more generally. To address this question, we modified our experimental timeline to label abGCs and wait three months for them to mature fully ([Figure 4A](#fig4){ref-type="fig"}) before imaging their responses to the same set of odors ([Figure 4B](#fig4){ref-type="fig"}) in the same mice before and after three weeks of PLX5622. In this case, we found no significant differences in the distribution of responses (p=0.45) ([Figure 4C](#fig4){ref-type="fig"}), median number of odors evoking a significant response (median (IQR) Control: 1.5 (0--6), PLX: 2 (0--5), p=1.00) ([Figure 4D](#fig4){ref-type="fig"}), or lifetime sparseness (median (IQR) Control: 0.096 (0--0.31), PLX: 0.099 (0--0.27), p=0.86) (Figure 4E). We verified that our imaging paradigm was stable since there was also no change in responses when we imaged the same mice for two sessions three weeks apart without any PLX treatment ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Even after 9 weeks of PLX treatment, the level of responsiveness remained stable in mature abGCs ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}).

![Microglial depletion after development has no effect on odor-evoked responses of abGCs.\
(**A**) Experimental timeline for microglial depletion after development of abGCs. AbGCs were labeled via lentivirus injection and allowed to mature for 3 months. A control imaging session was performed immediately before administration of PLX chow and the second imaging session occurred 3 weeks later. (**B**) Heatmap traces from the 100 ROIs with the largest odor-evoked Ca2+ signals across all mice ranked for each of 15 odors (molecular structures shown above). Black bar denotes odor time. Bottom, mean response time course for each odor across all ROIs. (**C**) Cumulative distribution showing that the distribution of responses (averaged across odors for each dendrite) is not different before and after PLX diet administration (Two sample Kolmogorov--Smirnov test, D = 0.087, p=0.45) and the noise distributions constructed from blank trials are also not different (D = 0.11, p=0.16). (**D**) Cumulative distribution showing the number of effective odors (odors that evoked responses above the ROC threshold 0.53, which was calculated across all dendrites from both groups). The median number of effective odors was not different between groups (Wilcoxon rank sum test, z = 0.0038, p=1.00). (**E**) Raincloud plot showing the distribution of lifetime sparseness across all dendrite. Above, kernel density estimate. Below, boxplot showing the median, interquartile range (box), and 1.5 times the interquartile range (whiskers) superimposed on a dot plot of all the data (one dot per dendrite). Median lifetime sparseness was not different between groups (Wilcoxon rank sum test, z = 0.18, p=0.87). n = 198 dendrites before and 185 dendrites after 3 weeks of PLX administration from three mice. ns, not significant.\
Figure 4---source data 1.This spreadsheet contains values from each dendrite for [Figure 4C,D and E](#fig4){ref-type="fig"}.](elife-50531-fig4){#fig4}

Synapse development in abGCs that mature in the absence of microglia {#s2-4}
--------------------------------------------------------------------

Since we found that microglial depletion reduces the functional responses of abGCs, we wondered if there were accompanying changes in excitatory synapses made on abGCs. We studied spines on the apical dendrites of abGCs in the EPL since our in vivo imaging showed lower calcium responses to odors in these dendrites, which could reflect fewer or weaker synaptic inputs. Four weeks after lentiviral labeling, we examined spines on apical dendrites in abGCs in tissue sections from control and PLX-treated mice ([Figure 5A,B](#fig5){ref-type="fig"}). We found higher spine density (median (IQR): Control: 0.30 (0.21--0.36) spines/µm, PLX: 0.40 (0.31--0.48) spines/µm, p=0.039) ([Figure 5C](#fig5){ref-type="fig"}), but smaller spine head volumes in PLX-treated mice (mean Control: 0.37 ± 0.03 μm^3^, PLX: 0.31 ± 0.02 μm^3^, p=0.057) ([Figure 5D](#fig5){ref-type="fig"}). Furthermore, most of the increase in spine density in PLX-treated mice was due to an increase in the density of filopodial spines that had similar spine head volumes as in control mice ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). In contrast, mushroom spines had significantly smaller head volumes in PLX-treated mice (mean Control: 0.45 ± 0.04 μm^3^, PLX: 0.36 ± 0.03 μm^3^, p=0.036) ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

![Microglial depletion during development reduces spine head volume in abGCs.\
(**A**) Experimental timeline for microglial depletion during development of abGCs. Mice were given control or PLX5622-containing chow on the same day that a lentivirus was injected into the RMS to label abGCs. Spine numbers and morphology were quantified 4 weeks later. (**B**) Above, sample images showing two apical dendrites from one cell that were analyzed in a control mouse (left) and PLX-treated mouse (right). Below, insets from the images shown above, showing spine morphology in more detail. (**C**) Spine density averaged across 1--5 apical dendrites from each abGC. Spine density was higher in PLX-treated mice (Wilcoxon rank sum test, z = −2.07, p=0.039). Bars indicate medians across cells (circles). (**D**) Cumulative distribution showing the volume of all spines analyzed. Inset, sampling distributions of the mean head volume obtained with the hierarchical bootstrap. The mean head volume (dark lines) was greater in control versus PLX-treated mice (hierarchical bootstrap, p=0.057). n = 810 spines from 17 abGCs from three control mice and 1551 spines from 17 abGCs from 4 PLX mice. \*p\<0.05.\
Figure 5---source data 1.This spreadsheet contains spine density values for each dendrite for [Figure 5C](#fig5){ref-type="fig"} and values for the head volume of each spine from each dendrite for [Figure 5D](#fig5){ref-type="fig"}.](elife-50531-fig5){#fig5}

We next investigated the electrophysiological correlates of the observed differences in spine head size by recording spontaneous excitatory postsynaptic currents (sEPSCs) in abGCs. We used the same timeline as our in vivo imaging experiments, namely microglial depletion beginning three weeks before lentiviral labeling, continuing until electrophysiological recordings from labeled cells in brain slices at five to six weeks post injection ([Figure 6A,B](#fig6){ref-type="fig"}). We found a similar frequency of sEPSCs in cells from control and PLX-treated mice (mean Control: 30.8 ± 2.2 Hz, PLX: 30.6 ± 2.4 Hz, p=0.48) ([Figure 6C](#fig6){ref-type="fig"}), but their amplitude was reduced (mean Control: 10.8 ± 0.6 pA, PLX: 9.0 ± 0.4 pA, p=0.007) ([Figure 6D](#fig6){ref-type="fig"}). Passive membrane properties including membrane resistance (median Control: 597 MΩ, PLX: 532 MΩ, p=0.31) and capacitance (median Control: 14.2 pF, PLX: 13.6 pF, p=0.61) were unchanged, signifying no differences in cell surface area or resting membrane properties ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). We also confirmed that our recording conditions were consistent by verifying that series resistance and the distance of the recorded cells from the mitral cell layer were not different between groups ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

![Microglial depletion during abGC development reduces the amplitude of excitatory synaptic currents but does not affect inhibitory synaptic currents.\
(**A**) Experimental timeline for electrophysiological recording in abGCs (**B**) Left, sample sections from raw traces recorded from abGCs in control (top) and PLX-treated (bottom) mice. Right, median EPSCs across all EPSCs detected from all mice. (**C**) Cumulative distribution showing the inter-event intervals from all recorded EPSCs. Inset, sampling distributions of the mean frequency obtained with the hierarchical bootstrap. The median frequencies (dark lines) were not significantly different (hierarchical bootstrap, p=0.48). (**D**) Cumulative distribution showing the amplitudes from all recorded EPSCs. Inset, sampling distributions of the mean amplitude obtained with the hierarchical bootstrap. The mean amplitude (dark line) was significantly higher in control cells (hierarchical bootstrap, p=0.0068). (**E**) Left, Sample sections from raw traces recorded from abGCs in control (top) and PLX-treated (bottom) mice. Right, median IPSCs across all IPSCs detected from all mice. (**F**) Cumulative distribution showing the inter-event intervals from all recorded IPSCs. Inset, sampling distributions of the median frequency obtained with the hierarchical bootstrap. The mean frequencies (dark lines) were not significantly different (hierarchical bootstrap, p=0.77). (**G**) Cumulative distribution showing the amplitudes from all recorded IPSCs. Inset, sampling distributions of the mean amplitude obtained with the hierarchical bootstrap. The mean amplitudes (dark lines) were not significantly different (hierarchical bootstrap, p=0.79). For EPSCs: n = 30 abGCs from four control mice and 33 abGCs from 4 PLX mice. For IPSCs: n = 29 abGCs from four control mice and 30 abGCs from 4 PLX mice (same mice in both cases and cells used for both EPSCs and IPSCs if the recordings met criteria stated in Materials and methods). ns, not significant; \*\*p\<0.01.\
Figure 6---source data 1.This spreadsheet contains the frequency and amplitude values for all detected events from each dendrite for [Figure 6C,D,F and G](#fig6){ref-type="fig"}.](elife-50531-fig6){#fig6}

To check whether there might be accompanying changes in inhibition that could offset or augment the observed changes in excitation, we also recorded spontaneous inhibitory postsynaptic currents (sIPSCs) in the same cells ([Figure 6E](#fig6){ref-type="fig"}). We found no difference in the frequency (p=0.77) ([Figure 6F](#fig6){ref-type="fig"}) or amplitude of sIPSCs (p=0.79) ([Figure 6G](#fig6){ref-type="fig"}), suggesting that abGCs that mature in the absence of microglia receive weaker excitatory inputs without noticeable accompanying changes in inhibition.

Microglial depletion after abGC development has no effect on synaptic inputs {#s2-5}
----------------------------------------------------------------------------

Since there was no significant change in functional responses in abGCs that matured before microglia ablation, we checked whether synaptic inputs were also unchanged in this condition using the same experimental timeline as before and recording sEPSCs in abGCs that experienced three weeks of microglial depletion after three months of maturation ([Figure 7A](#fig7){ref-type="fig"}). There was no significant change in the frequency (p=0.76) ([Figure 7B](#fig7){ref-type="fig"}) or amplitude of sEPSCs (p=0.09) ([Figure 7C](#fig7){ref-type="fig"}). Inhibitory inputs were also unchanged ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). These results suggest that microglial depletion only affects synaptic inputs to abGCs when it occurs during the first five to six weeks of the cells' development rather than after maturation.

![Microglial depletion after abGC development has no effect on excitatory synaptic currents.\
(**A**) Experimental timeline for electrophysiological recordings in abGCs after their development (**B**) Left, Sample sections from raw traces recorded from abGCs in control (top) and PLX-treated (bottom) mice. Right, median EPSCs detected from all mice. (**C**) Cumulative distribution showing the inter-event intervals from all recorded EPSCs. Inset, sampling distributions of the mean frequency obtained with the hierarchical bootstrap. The mean frequencies (dark lines) were not significantly different (hierarchical bootstrap, p=0.76). (**D**) Cumulative distribution showing the amplitude from all recorded EPSCs. Inset, sampling distributions of the mean frequency obtained with the hierarchical bootstrap. The mean amplitudes (dark lines) were not significantly different (hierarchical bootstrap, p=0.093). n = 23 abGCs from three control mice and 27 abGCs from 3 PLX mice. ns, not significant.\
Figure 7---source data 1.This spreadsheet contains the frequency and amplitude values for all sEPSCs from each dendrite for [Figure 7C and D](#fig7){ref-type="fig"}.](elife-50531-fig7){#fig7}

Discussion {#s3}
==========

We delineate an important role for microglia in the regulation of adult-born neuron integration. Our study adds to the growing literature documenting physiological and/or behavioral effects following microglial depletion from the healthy adult brain ([@bib49]; [@bib63]; [@bib53]). Importantly, our study is the first to link microglial depletion directly to changes in the in vivo activity and functional inputs of a specific affected cell population. We show that eliminating microglia has functional consequences for abGCs incorporating into the circuitry of the OB, reducing their responses to stimuli. Furthermore, we go on to investigate the physiological mechanisms and show that the dampened responses we observe are consistent with reduced spine volume and weaker excitatory inputs in neurons that develop in the absence of microglia.

Methodological considerations {#s3-1}
-----------------------------

Several technical caveats must be acknowledged to allow proper interpretation of our study. While ablation of microglia with PLX5622 is highly efficient, it necessarily involves a period of microglial cell death, and it is unknown how this debris may be cleared or what effects it may have on other cell types. We have attempted to minimize these effects by beginning experiments at least three weeks after initiation of PLX5622 treatment, when the number of microglia should have reached steady state levels ([@bib21]), but we cannot exclude the possibility of long-term effects resulting from microglial cell death. Encouragingly, there seems to be no upregulation of cytokines or GFAP with PLX treatment generally ([@bib21]) or in the OB, specifically ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}; [@bib53]) in contrast to other methods for microglial depletion, which may cause a significant increase in GFAP+ astrocytes and a cytokine storm ([@bib8]). However, we acknowledge that the array of possible inflammatory responses to microglial disruption is still poorly understood ([@bib37]) and may involve both responses to microglial cell death as well as reactions to the absence of normal homeostatic cues. Future work will be needed to characterize changes in crosstalk among different cell populations after microglial depletion and implications for the inflammatory environment. However, inflammation in the OB has been shown to generally reduce adult-born neuron numbers ([@bib34]) and spine density ([@bib12]) as opposed to increasing spine density and reducing excitatory synapse strength as we show here, so it is unlikely that undetected inflammation relating to microglial depletion can fully account for the results we observe.

We also note that microglial depletion with PLX5622 is brain-wide. AbGCs receive local inputs from within the OB as well as feedback from other cortical areas and neuromodulatory inputs ([@bib35]), so we cannot unambiguously attribute the effects on abGCs to changes within the OB. Future work will be necessary to investigate whether there is a change in the balance of distal (predominantly feedforward) and proximal (mostly feedback) inputs or instead a more general effect on excitatory synapse maturation and/or maintenance.

AbGCs in the olfactory circuit {#s3-2}
------------------------------

AbGCs become responsive to odor stimuli soon after they arrive in the OB and then undergo a period of functional refinement during which their initially broadly tuned responses become more selective ([@bib67]) (although there may also be a subpopulation of abGCs that shows broadening of responses with maturation [@bib51]; [@bib67]). Although the mechanism behind this increase in stimulus selectivity is not well-understood, it may involve both a decrease in some aspects of excitability ([@bib9]; [@bib46]), especially dendritic excitability ([@bib67]), as well as selective reorganization of synaptic inputs such that mature abGCs become more responsive to a particular glomerular module at the expense of other inputs. We propose that abGCs in PLX-treated mice experience a normal drop in excitability (likely regulated by cell-intrinsic mechanisms) without a concomitant selective strengthening of specific synaptic inputs, leading to sparser odor responses ([Figure 8](#fig8){ref-type="fig"}). This is consistent with the higher density of more filopodial-like spines in PLX-treated mice (characteristic of abGCs at an earlier stage of maturation [@bib7]) along with smaller mushroom spines ([Figure 5](#fig5){ref-type="fig"}) and lower amplitude sEPSCs ([Figure 6](#fig6){ref-type="fig"}). It is also possible that abGCs in PLX-treated mice could have generally lower excitability, but we regard this as unlikely since excitability has been mainly shown to affect survival rather than synaptic inputs in abGCs ([@bib38]), in contrast to what we observe here. Future work will be needed to disentangle the different aspects of abGC maturation and more fully elucidate which are affected by microglia.

![Summary of results and model for the role of microglia in abGC maturation.\
Young abGCs enter existing circuits and begin to make synapses, a process that involves the extension of filopodial spines that sample potential synaptic partners ([@bib7]). In control mice, abGCs undergo a coordinated process of synaptic formation and elimination ([@bib42]; [@bib56]), which leads to an increasing number of mushroom spines with mature synapses and higher frequency and amplitude excitatory synaptic currents as they mature ([@bib69]; [@bib32]; [@bib7]). Maturation likely also involves a decrease in dendritic excitability ([@bib9]; [@bib46]; [@bib67]), such that stronger, coordinated synaptic inputs with particular odor tuning are necessary to activate mature abGCs, leading to more selective odor responses. In mice treated with PLX5622 to ablate microglia throughout the time course of abGC development, we hypothesize that abGCs undergo some parts of the maturation process, but not others. We show that aspects of excitability, such as input resistance, mature normally, and overall spine density increases to levels even above controls. However, synapses fail to mature, leading to overall smaller spines and lower amplitude sEPSCs. This may contribute to lower odor responsiveness in abGCs that have matured in the absence of microglia.](elife-50531-fig8){#fig8}

Though the effects on synaptic development that we observe in individual cells are modest (\~15% reduction in median sEPSC amplitude in PLX-treated mice, [Figure 6C](#fig6){ref-type="fig"}), these effects combined nonlinearly across many synapses likely become important near response threshold in vivo. Indeed, we observed larger effects on calcium responses recorded in vivo (median response amplitudes halved across all abGCs imaged in each PLX-treated animal, [Figure 2---figure supplement 5D](#fig2s5){ref-type="fig"}), which likely represent dendritic calcium spikes or global calcium events accompanying somatic action potentials that result from simultaneous activation of many feedforward and feedback synapses ([@bib16]; [@bib17]).

Microglia-neuron interactions in the adult brain {#s3-3}
------------------------------------------------

Though several studies have examined microglial motility ([@bib45]) and interactions between microglia and neuronal elements ([@bib66]; [@bib64]; [@bib61]), it has been unclear whether microglia interact with synapses more often than would be expected by chance, given the dense synaptic milieu of the adult brain and the high degree of microglial process motility. Using automated methods to segment microglial processes from in vivo two-photon time-lapse imaging experiments and shuffle the resulting images for comparison, we demonstrated targeted motility towards mushroom spines on abGCs, which are likely to contain established excitatory synapses ([@bib69]). In the absence of microglia, we suggest that fewer spines attain mushroom morphology, leading to overall reduced spine volume and correspondingly weaker excitatory synapses. Concomitantly, we observed an increase in spine density in microglia-ablated animals, which is likely accounted for by filopodial spines which did not have functional or stable synapses (since we did not see an accompanying increase in the frequency of synaptic currents in PLX-treated mice). One potential unifying hypothesis is that microglia may prune weaker synapses, allowing stronger synapses to strengthen further ([@bib62]; [@bib59]; [@bib64]; [@bib48]). However, unlike other sensory systems that experience largescale pruning events during development, abGCs develop an increasing number of synapses over time ([@bib9]; [@bib7]). This does not preclude a role for microglia in pruning inputs to these cells (in a situation in which synaptic formation occurs at a higher rate than elimination) but suggests that if this occurs, it is likely to be more subtle and difficult to detect with conventional methods. Although we did not directly observe pruning of dendritic spines in abGCs in our time lapse imaging experiments, it remains possible that microglia could prune presynaptic elements ([@bib59]; [@bib23])(which we did not image) or that our frame rate was too slow to observe such events ([@bib68]).

In addition to synaptic pruning, microglia may be involved in promoting synaptic strengthening. Deficits in microglial CX3CR1 have been linked to weaker synapses and impaired connectivity ([@bib74]; [@bib53]) as well as delays in maturation of the AMPA/NMDA ratio ([@bib28]). It is still unclear whether these effects, similar to those that we observe in the PLX ablation model, are related to differences in spine surveillance and direct microglial-neuron signaling or due to altered microglial behavior, including changes in release of moderating factors or interactions with other cell types, such as astrocytes. We expect that in the future, a new generation of tools for more specifically modifying microglial gene expression and function during defined time windows will help clarify the mechanisms by which microglia affect synaptic development.

In addition, although most previous work has focused on microglial regulation of synapses, microglia may also regulate neuronal excitability through other mechanisms ([@bib36]; [@bib50]). Accordingly, although we found no differences in passive membrane properties between abGCs in control versus PLX-treated animals, we cannot exclude additional possible effects of microglia on nonsynaptic aspects of abGC development, including active dendritic properties, that could also contribute to the reduced responsiveness we observe when microglia are ablated.

Timing of microglial depletion {#s3-4}
------------------------------

While our results suggest that the effect of microglial depletion is specific to developing abGCs (since our results with microglial depletion after abGC development did not reach statistical significance in most cases), we saw similar trends in reduced responses and excitatory inputs regardless of the timing of microglial depletion. This could be because lentiviral labeling is an imperfect method for isolating a single cohort of abGCs (so some abGCs in the 'after development group' may still be at an earlier stage of development -- see discussion of newcomer cells in [@bib67]). Another possibility is that microglial depletion also affects mature abGCs, although to a lesser extent than developing abGCs. This could be because microglia may be involved in the general maturation or strengthening of newly formed excitatory synapses in GCs, and even mature GCs have high rates of synapse formation (and elimination) compared to cells in other brain regions ([@bib42]; [@bib56]). In this scheme, developing abGCs would demonstrate the most significant phenotype due to their higher rates of spine dynamics, but even mature GCs might accrue smaller effects over time.

The larger effect of microglial depletion on developing rather than mature adult-born neurons highlights the role of microglia during developmental stages and may explain why some studies have not found significant effects of microglial depletion in other areas of the healthy adult brain ([@bib21]; [@bib63]).

Consequences for olfactory processing {#s3-5}
-------------------------------------

The reduced activity that we observe in mature abGCs after microglial depletion is consistent with increased activity in the principal cells they inhibit ([@bib53]). Since reduced inhibition from GCs to OB principal neurons has been directly linked to an increase in the time needed to discriminate odors in challenging olfactory tasks ([@bib1]), this alteration in the OB circuitry could have functional consequences ([@bib18]). Furthermore, given that abGCs may have an outsized role in the plasticity that underlies complex olfactory behaviors ([@bib6]; [@bib30]; [@bib40]), microglial regulation of their development may contribute to ongoing plasticity in the olfactory system.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                     Designation                      Source or reference   Identifiers                                                      Additional information
  (species) or resource                                                                                                                                     
  --------------------------------- -------------------------------- --------------------- ---------------------------------------------------------------- -----------------------------------------------------------------------
  Genetic reagent (*M. musculus*)   CX3CR1-GFP heterozygote          [@bib30]              Cat\# Jax: 008451                                                

  Genetic reagent (lentivirus)      pLenti-TRE-t2A-dTomato-GCaMP5    [@bib67]                                                                               Produced in house (see Materials and methods, \'Viral Vectors\')

  Genetic reagent (lentivirus)      pLenti-TRE-t2A-dTomato-GCaMP6s   [@bib67]                                                                               Produced in house (see Materials and methods, \'Viral Vectors\')

  Genetic reagent (lentivirus)      pLenti-TRE-t2A-dTomato           [@bib67]                                                                               Boston Children's Hospital Viral Core

  Genetic reagent (lentivirus)      pLenti-hSynapsin - tTad          [@bib26]                                                                               Produced in house or by Boston Children's Hospital Viral Core

  Antibody                          Anti-Iba1\                       Wako                  Cat \# 019--19741\                                               1:500
                                    (Rabbit polyclonal)                                    RRID:[AB_839504](https://scicrunch.org/resolver/AB_839504)       

  Antibody                          Anti-GFAP (Rabbit polyclonal)    Dako                  Cat \# Z0334\                                                    1:1000
                                                                                           RRID:[AB_10013382](https://scicrunch.org/resolver/AB_10013382)   

  Antibody                          Anti-BrdU (Rat monoclonal)       Abcam                 Cat \# ab6326                                                    1:200

  Antibody                          Anti-NeuN (Mouse monoclonal)     Millipore             MAB377                                                           1:200

  Antibody                          Anti-CD45 (Rat monoclonal)       Biolegend             103116                                                           1:100 (final concentration of 2 µg/mL)

  Antibody                          Anti-CD11b\                      Biolegend             101217                                                           1:200 (final concentration of 2.5 µg/mL)
                                    (Rat monoclonal)                                                                                                        

  Antibody                          Anti CD16/CD32 (Rat)             BD Bioscience         553141                                                           1:50 (final concentration of 10 µg/mL)

  Chemical compound, drug           PLX5622                          Plexxikon             PLX5622                                                          1200 mg/kg

  Chemical compound, drug           BrdU                             Sigma Aldrich         Cat \# 19--160                                                   100 mg/kg

  Software, algorithm               FlowJo                           FlowJo                Version 10.2                                                     <https://www.flowjo.com/solutions/flowjo/downloads/previous-versions>

  Software, algorithm               Imaris                           Oxford Instruments    Versions 8 and 9                                                 <https://imaris.oxinst.com/>

  Software, algorithm               pClamp                           Molecular Devices     Version 10.3                                                     

  Software, algorithm               Matlab                           Mathworks             Version 2019b                                                    

  Software, algorithm               MiniAnalysis                     Synaptosoft           Version 6.0.3                                                    <http://www.synaptosoft.com/MiniAnalysis/>

  Other                             Blue Dead Cell Stain             ThermoFisher          L34961                                                           

  Other                             Counting Beads (CountBright)     ThermoFisher          C36950                                                           
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mice {#s4-1}
----

Mice were C57BL/6J males (Jackson Laboratories) or CX3CR1-GFP heterozygotes (Jackson Laboratories stock \#008451) ([@bib30]) that were 8 to 12 weeks-old at the beginning of the experiment. Mice were singly housed after chronic cranial window implantation or housed with littermates for experiments that did not require an implant. In both cases, they were housed on a 12 hr reversed light/dark cycle after window implantation or viral injection. Littermates were randomly assigned to experimental groups (control vs. PLX). All procedures were performed using approved protocols in accordance with institutional (Harvard University Institutional Animal Care and Use Committee) and national guidelines.

Viral vectors {#s4-2}
-------------

For all experiments involving lentiviral labeling of abGCs, we used a Tet-Off lentiviral system ([@bib26]) with one construct expressing the transactivator tTAad under control of a synapsin promotor (lenti-STB) and a second construct expressing structural and/or activity markers. For spine quantification in fixed tissue ([Figure 5](#fig5){ref-type="fig"}) and electrophysiology ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}), we used lenti-STB and lenti-dTomato produced by the Boston Children's hospital. For imaging microglia-spine interactions ([Figure 1](#fig1){ref-type="fig"}), we used lenti-STB and lenti-dTomato-t2A-GCaMP5 and for all experiments measuring odor responses ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) we used lenti-STB and lenti-dTomato-t2A-GCaMP6s produced in house. VSV-G pseudotyped lentiviral vectors were produced by transfection of human embryonic kidney cells (HEK293FT) with third-generation lentivirus plasmids using lipofection (Mirus TransIT−293). Supernatant was collected 48 hr after transfection and concentrated using ultrafiltration (Centricon Plus-20 PLGC centrifuge filter units).

Lentiviral injections and cranial window surgeries {#s4-3}
--------------------------------------------------

Reproduced from [@bib67]:

\"Mice were anesthetized with an intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg) and body temperature was maintained at 37°C by a heating pad. A small craniotomy was made bilaterally over the RMS injection sites (coordinates from bregma: A +3.3, L +0.82, from the brain surface: V-2.9 and −2.7) and 250 nL of lentivirus (1:1 mixture of both constructs or 1:50 dilution of the tTA-containing construct to achieve sparser labeling for spine quantification in [Figure 5](#fig5){ref-type="fig"}) was injected at each of the two depths using a pulled glass micropipette (tip diameter approximately 10--20 um).\' For cranial windows, the surface of the brain was kept moist with artificial cerebrospinal fluid (125mMNaCl, 5mMKCl, 10mMGlucose, 10mMHEPES, 2 mM CaCl2 and 2 mM MgSO4 \[pH 7.4\]) and Gelfoam (Patterson Veterinary) and a glass window consisting of two 3 mm No. one coverslips (Warner) glued together with optical glue (Norland Optical Adhesive 61) was implanted as previously described ([@bib2]). For mice used for awake imaging, Kwik Sil (World Precision Instruments) was placed between the coverslip and the brain surface to reduce movement. In this case, the coverslip consisted of two 3 mm and one 4 mm No. 0 coverslips forming a plug ([@bib13]) with the 4 mm coverslip cut with a diamond knife to fit between the mouse's eyes. In both cases, the edges around the coverslip were sealed with Vetbond (3M) and then C and B-Metabond dental cement (Parkell, Inc). A custom-made titanium headplate (eMachineShop) was cemented to the skull. After surgery, mice were treated with carprofen (6 mg/kg) every 24 hr and buprenorphine (0.1 mg/kg) every 12 hr for 5 days.\"

Two-photon imaging of microglia-spine interactions ([Figure 1](#fig1){ref-type="fig"}) {#s4-4}
--------------------------------------------------------------------------------------

A custom-built two-photon microscope ([@bib70]) was used for in vivo imaging. Fluorophores were excited and imaged with a water immersion objective (20x, 0.95 NA, Olympus) at 950 nm using a Ti:Sapphire laser (Mai Tai HP, Spectra-Physics). The point spread function of the microscope was measured to be 0.66 × 0.66×2.26 µm. Image acquisition and scanning were controlled by custom-written software in Labview. Emitted light was routed through two dichroic mirrors (680dcxr, Chroma and FF555- Di02, Semrock) and collected by two photomultiplier tubes (R3896, Hamamatsu) using filters in the 500--550 nm range (green channel, FF01-525/50, Semrock) and 572--642 nm range (red channel, FF01-607/70, Semrock). Fields of view were 75 × 75 µm square spanning 800 × 800 pixels. Z-stacks of approximately 30 µm depth with a 1 µm z step for both channels (16 bit) were taken every 3 min (0.5 Hz frame rate with 3x averaging during acquisition) for periods of 30--90 min. Two or three fields of view were imaged in each mouse.

Analysis of microglia-spine interactions ([Figure 1](#fig1){ref-type="fig"}) {#s4-5}
----------------------------------------------------------------------------

Since both channels exhibited bleed-through with our imaging parameters, the ImageJ spectral unmixing plugin (Author: J. Walter) was used to calculate and apply unmixing matrices for each image stack prior to further analysis. In Fiji, spine heads were delineated manually for each time point in the frame where they appeared brightest using the oval or polygon tools and ROI Manager and classified as either mushroom (spines whose spine head was wider than the spine neck at all timepoints) or filopodial (without a well-defined head). The Weka segmentation plugin ([@bib4]) was used to perform binary segmentation of microglial processes from background after training on five frames (that were fully segmented manually) selected to represent a variety of microglial morphologies and brightness variation across the three mice. To optimize our resolution, we segmented very conservatively by using z stacks to mark microglial processes only in the plane where they appeared brightest. This strategy combined with only delineating spine heads in the brightest frame means that we only detected the closest interactions between microglial processes and spine heads. The features chosen for segmentation training in Weka were Gaussian blur, Sobel filter, Hessian, and Difference of Gaussians. This approach allowed us to segment complex microglia morphology from background automatically in every image frame and obviated the need for corrections for bleaching or variations in brightness across different imaging fields. Imaging frames that were too dim to segment (usually due to loss of immersion water) were excluded. Each segmented image stack was checked manually to ensure that any residual bleed-through from the red channel did not appear in the segmentation. After segmentation, ROIs representing spine heads were exported to Matlab using a custom-written macro with the command getSelectionCoordinates. In Matlab, the ROIs were loaded onto the segmented image and the mean value of the binary microglia channel within each ROI at each timepoint (0 if there was no colocalization or up to one if all pixels were colocalized with a segmented microglial process) was measured. The frame was quantified as containing a microglia-spine interaction if the value of colocalization was greater than 0.05 (at least 5% of the spine head area overlapped by a microglial process). To compare the overlap between microglial processes and spine heads in the real data compared to what might be expected by chance, we iteratively translated the microglia channel relative to the marked spine head ROIs to calculate distributions for all the measured interaction parameters ([@bib15]). To do this, we took the original segmented image stack and translated it horizontally, vertically, or horizontally and vertically first by the maximum spine width across the whole data set (\~32 pixels) to ensure none of the offsets would overlap the real data and then iteratively by the mean spine width (\~10 pixels) to ensure each offset would be as uncorrelated as possible for a total of 231 offsets. Note that this method likely underestimates the significance of interactions in the real dataset because microglia cell bodies were never colocalized with spines in the real dataset (dendrites overlapping microglia cell bodies were not chosen for imaging) but were likely colocalized and quantified as interacting with spines in some of the offset datasets. To produce [Video 2](#video2){ref-type="video"}, frames were first registered with the MultiStackReg plugin (Author: Brad Busse) based on the magenta channel and bleaching was corrected with histogram matching in ImageJ (these steps were not necessary for analysis because we segmented each image frame separately as described above).

Two-photon imaging of odor-evoked responses ([Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}) {#s4-6}
---------------------------------------------------------------------------------------------------------------

Animals were matched in littermate pairs before cranial window surgery. All animals with a clear region of the cranial window and visible lentiviral expression were used for imaging (2/4 control mice and 2/4 PLX-treated mice in the first experiment, 1/2 control mice and 1/2 PLX mice in a second experiment, and 2/4 control mice and 4/4 PLX-treated mice in a third experiment). Imaging was performed at 930 nm with the same two-photon microscope described above.

Reproduced from our previous work ([@bib67]):

\"Animals were anesthetized with an intraperitoneal injection of ketamine and xylazine (90% of dose used for surgery) and body temperature was maintained at 37°C by a heating pad. Frame rates were 4 Hz, the pixel size was 0.5 μm, and fields of view measured 150 × 150 μm. To locate regions for imaging, a low magnification z stack (\~300--500 μm square) at slow scanning speed (usually 0.5 Hz) with a 1--2 μm z step was taken from the surface of the dura to the granule cell layer. Planes with many dendrites perpendicular to the imaging axis were chosen for imaging during odor stimulation.\"

Two-photon imaging in awake animals ([Figure 3](#fig3){ref-type="fig"}) {#s4-7}
-----------------------------------------------------------------------

A subset of the animals that were imaged under anesthesia were chosen for awake imaging (all animals that had sufficiently stable cranial windows were chosen from each of the experiments). Animals were water-restricted beginning 1--2 days before being handled and accustomed to head-fixation in a restraining tube ([@bib24]) for 1--2 days with manual delivery of water rewards (approximately 30 min sessions each). They were then acclimated to the sound of the scan mirrors and odor delivery (using the full odor set) on the day before imaging with manual delivery of water rewards before imaging and periodically between sets of repetitions. The same protocol was repeated for 1 or 2 days of imaging for each mouse.

Odor stimulation {#s4-8}
----------------

Odor lists are found in [Table 1](#table1){ref-type="table"}. Odors (Sigma) were delivered with a custom-built 16 channel olfactometer at a nominal volumetric concentration of 16% (v/v) in mineral oil and further diluted by 16 times in air to a final concentration of approximately 1% (except for isoeugenol which was not diluted in mineral oil and therefore had a final concentration of approximately 6.25%). Odors were presented for 2 s with an interstimulus interval of 40 s with 3--5 times repetitions. The order of odor delivery was not randomized. A 'no odor' trial with the same parameters but in which no odor valve opened was included with each set of repetitions. Odors were delivered through a mask with balanced input and output air flow that also allowed us to record respiration ([@bib22]). The positioning of the mask was adjusted daily to ensure optimal signal to noise. A photoionization detector (miniPID, Aurora Scientific) was used to confirm that odor concentrations were consistent between trials with these parameters. Odors were replaced before each set of experiments.

In vivo imaging analysis ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) {#s4-9}
------------------------------------------------------------------------------------------------------------------------

Data were analyzed offline using custom-written scripts in MATLAB (Mathworks). Experimenters were blind to fluorescence changes during data analysis but not to experimental group.

Regions of interest (ROIs) {#s4-10}
--------------------------

Dendritic ROIs from abGCs were chosen based on average intensity projections in the dTomato channel as previously described ([@bib67]). Fields of view were non-overlapping and separated by at least 100 μm to minimize the chance of the same dendrites appearing in multiple fields of view. Z stacks of each imaging region were taken with a 2 μm z step from the surface of the dura down to the convergence of GC dendrites into a single apical dendrite. The density of labeling precluded tracing of all dendrites back to their parent cell, but we used these z stacks to ensure that multiple ROIs were not chosen from the same dendrite. Therefore, these data should be considered a sample from a population of dendrites rather than cells since some dendrites may have originated from the same cell. We previously estimated with our labeling and imaging strategy that about 1.4 times more dendrites than cells are represented in the dataset (and this is almost certainly an overestimate since this was based on the first week of imaging, where labeling is significantly sparser than at later timepoints). For ablation after development ([Figure 4](#fig4){ref-type="fig"}), the same fields of view were imaged before and after PLX treatment. For [Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}, we chose matching ROIs for the two sessions (any ROIs without similar morphology between the two sessions were excluded as described previously [@bib67]) to quantify how much our imaging conditions changed between sessions without PLX treatment. However, we opted to choose ROIs independently for [Figure 4](#fig4){ref-type="fig"} since matching ROIs always results in the exclusion of many ROIs, reducing sample size.

Motion correction {#s4-11}
-----------------

To correct for fast lateral motion and image drift, all image frames for a given field of view were aligned to the average of the first trial using cross-correlation based on rigid body translation (ImageJ plugin Moco)([@bib14]). Frames with out-of-frame motion were removed based on the cosine similarity between each frame and the average intensity projection of the first trial (or the user-determined trial with the least motion for awake imaging). Image frames with cosine similarity that differed by more than 25% (30% for awake imaging) from the mean value for the user-determined best trial for that field of view or more than 20% (15% for awake imaging) from the mean of the baseline period for that trial were discarded. In some trials, immersion water dried up or laser power fluctuated, so trials were removed if their average brightness was less than half of the brightness of the average of the first three trials or if difference in brightness between the baseline and odor periods was greater than three times the standard deviation of brightness in the first trial. The entire trial was removed if, after these corrections, it contained less than 75% of the original frames during either the baseline or odor analysis period.

Fluorescence changes {#s4-12}
--------------------

The average intensity in the GCaMP channel was calculated for each ROI, for each frame and for each odor. A response value for each cell-odor pair was calculated as the average ΔF/F~σ~ value over the odor analysis period (5 s following odor onset) where F~σ~ represents the standard deviation of fluorescence during the baseline period. We used F~σ~ because we found that in many cases the baseline GCaMP6s fluorescence was so low in abGC dendrites that we could not reliably subtract the background as described previously ([@bib67]). Bleaching was corrected by fitting a single exponential to the florescence during the baseline period and taking the value at the end of the baseline period as the baseline mean, only for ROIs where the fluorescence during the last 2.5 s of the baseline period was greater than 1.1 times the fluorescence during the first 2.5 s. If, after correction for bleaching, baseline F~σ~ was greater than 30% of the mean baseline fluorescence, that ROI was considered too noisy and was removed from the analysis.

Event detection ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) {#s4-13}
---------------------------------------------------------------------------

Events were detected separately in each trace using the calculated ROC threshold (see next section) and any frames that were included in an event in any repeat were averaged across all repeats to obtain a mean event trace and the mean value in a 1 s period around the peak in this mean trace was then calculated as the average response to that odor. For latency, the mean latency across repeats was calculated for all repeats that had detected events.

Thresholds {#s4-14}
----------

For all figures where a threshold was applied to the data, thresholds were calculated based on the distribution of 'no odor' trials. An area under the receiver operating curve analysis was performed and the lowest threshold yielding a 10% false positive rate was chosen. Thresholds were calculated for each figure by combining responses from both control and PLX-treated groups and performing ROC analysis on the combined data. For event detection, we used ROC analysis to find the optimal combined threshold for the number of frames and standard deviation above baseline and chose the threshold that gave closest to a 10% false positive rate.

Lifetime sparseness {#s4-15}
-------------------

After applying a threshold to the data, we used the following equation to calculate lifetime sparseness: ([@bib72])$$LS = \frac{\left( {\sum_{j = 1}^{m}\frac{r_{j}}{m}} \right)^{2}}{\left( {\sum_{j = 1}^{m}\frac{{r_{j}}^{2}}{m}} \right)}$$where m = number of odors, $r_{j}$ = response of the neuron to odor j.

If all stimuli activate a cell nearly uniformly, LS will be close to 1, and if only a small fraction of the stimuli activate a cell significantly, LS will be close to 0. For any cells with all responses below threshold, we set LS = 0, interpreting this as the sparsest possible representation.

Temporal dynamics {#s4-16}
-----------------

Principal component analysis of the time course of responses was performed in Matlab using centered data and singular value decomposition as described previously ([@bib71]). To compare time courses for the control and PLX-treated groups, principal components were calculated on each dataset (all traces from all cell-odor pairs) separately and the angle between the two spaces spanned by the coefficient vectors for the first three principal components from the beginning to the end of the odor analysis period was calculated. Then a permutation test was performed in which the group to which each trace belonged was shuffled 1000 times, and the angles between new coefficient vectors were calculated based on random division into two groups of the same size as the original datasets. The actual angle was then compared to this distribution to obtain a p value.

Respiration measurements {#s4-17}
------------------------

Peaks were extracted from respiration traces using the findPeaks function in Matlab with a minimum peak distance of 10 Hz.

Raincloud plots {#s4-18}
---------------

Raincloud plots of the type in [Figure 2G](#fig2){ref-type="fig"} were created using the Matlab version of the RainCloudPlots package ([@bib3]).

Microglial depletion with CSF1R inhibitor PLX5622 {#s4-19}
-------------------------------------------------

CSF1R inhibitor PLX5622 was generously provided by Plexxikon (Berkeley, CA) and mixed into standard rodent diet at 1200 mg per kilogram of chow (Research Diets: AIN-76A diet). Control diet was formulated identically, but without the inhibitor.

Flow cytometry ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) {#s4-20}
--------------------------------------------------------------------------

Microglial depletion was confirmed via flow cytometry. A single-cell suspension enriched for microglia was generated as previously described (Hammond et al., Immunity 2019). Briefly, mice were deeply anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) and transcardially perfused with 20 mL of cold Hank's balanced salt solution (HBSS, GIBCO, 14175--079). Bulbs and brains were minced using a razor blade (Electron Microscopy Science, 71960) and homogenized using a dounce tissue grinder (Wheaton, 357542). Microglia were enriched via centrifugation in 40% Percoll (Sigma-Aldrich, 17-0891-01) at 500 g for 1 hr at 4°C. Samples were incubated for 20 min with Blue Dead Cell Stain (Thermo Fisher, L34961) and Fc blocking antibody (Rat Anti-Mouse CD16/CD32, BD Bioscience, 553141) in HBSS + 2 mM EDTA. Cells were additionally stained for 20 min with antibodies against CD45 (Biolegend, 103116) and CD11b (Biolegend, 101217) in buffer (HBSS + 2 mM EDTA + 0.5% BSA).

Counting Beads (CountBright, Thermo Fisher Scientific, C36950) were added and samples analyzed using a FACS Aria II 'SORP'. All events were collected until a total of 8000 counting beads had been acquired for each sample. The data were analyzed in FlowJo 10.2.

BrdU injections ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}) {#s4-21}
---------------------------------------------------------------------------

Mice received two intraperitoneal injections of BrdU (Sigma, 100 mg/kg in 0.9% saline) 12 hr apart.

Fixed tissue preparation {#s4-22}
------------------------

Mice were deeply anesthetized with a ketamine/xylazine mixture and perfused transcardially with 20 mL of PBS (pH 7.4) first, followed by 30--50 mL of 4% paraformaldehyde (diluted from 16% stock, Electron Microscopy Sciences) in 0.1 M phosphate buffered saline (pH 7.4). Brains were removed from the skull and placed in 5 ml 4% paraformaldehyde for 2 hr. They were then rinsed with PBS and one hemisphere for each mouse was sliced coronally at 100 μm with a vibratome (Leica) for imaging of dTomato-labeled abGC spines (Figure 5), while the other hemisphere was sliced sagitally at 35--40 μm for immunostaining.

Immunohistochemistry {#s4-23}
--------------------

For Iba-1 staining, 3--4 slices per mouse spanning the olfactory bulb were permeabilized and blocked with a solution containing 0.1% Triton X-100 (Fisher), and 5% goat serum in PBS for 1 hr at room temperature or blocked with Starting Block (ThermoFisher) with 0.3% TritonX-100 for 1 hr at room temperature and then incubated overnight at 4°C with the primary antibodies rabbit anti-Iba-1 (Wako: 019--19741, RRID:[AB_839504](https://scicrunch.org/resolver/AB_839504)) at 1:500 or rabbit anti-GFAP (Dako: Z0334, RRID: [AB_10013382](https://scicrunch.org/resolver/AB_10013382)) at 1:1000 and then secondary antibodies (Alexa goat-647 anti-Rabbit) for 2 hr at room temperature. For BrdU/NeuN staining, one of every eight slices per mouse was chosen. Slices were washed in PBS with 0.1% Triton X three times for five minutes each before being incubated for in 2N HCl for 10 min at room temperature and then 20 min at 37°C. They were then placed in 0.1M Boric Acid buffer for 15 min and washed again three times with PBS. All slices were then incubated in starting block (ThermoFisher) with 0.3% Triton X for one hour before being staining in in PBS with 0.3% Triton X with rat anti-BrdU (Abcam: 6326 at 1:200), and mouse anti-NeuN (Millipore: MAB377 at 1:200) primary antibodies for 36--48 hr at 4°C and then secondary antibodies (Alexa Fluor 488 and 594 at 1:200) for 2 hr at room temperature. Slices were treated with 0.2% w/v Sudan Black in 70% EtOH for 5 min before mounting.

Confocal imaging and quantification {#s4-24}
-----------------------------------

Slices were mounted with DAPI mounting media (Vectashield DAPI) and imaged with a confocal microscope (LSM 880, Zeiss). Reported cell densities were calculated based on distances in fixed tissue, uncorrected for volume changes due to fixation and mounting. All imaging and quantification were performed blind to the experimental group of the animal (PLX-treated or control).

Iba1 and GFAP quantification ([Figure 2---figure supplements 2](#fig2s2){ref-type="fig"} and [3](#fig2s3){ref-type="fig"}) {#s4-25}
--------------------------------------------------------------------------------------------------------------------------

For the 1- and 4 week timepoints, one z-stack per animal was imaged at 10X with pixel size 0.42 × 0.42×1 μm spanning the thickness of the slice. For the 9 week timepoint, two z-stacks per animal were imaged at 20X and the counts from both were averaged. Stacks were imaged with pixel size 0.59 × 0.59×1 μm spanning 10 μm and converted to maximum intensity projections. The polygon tool was used to outline the granule cell layer in each image and the area was measured. Iba-1 or GFAP positive cells were counted in this area manually using the Cell Counter plugin on maximum intensity projection images in ImageJ. Cells were counted only if the cell body was fully included in the image stack.

BrdU quantification ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}) {#s4-26}
-------------------------------------------------------------------------------

For BrdU/NeuN, two z-stacks per OB (one centered dorsally and one centered ventrally) were taken at 20X with pixel size 0.52 × 0.52×0.89 μm spanning 9.8 μm. BrdU counts were performed using the automatic spots function in Imaris (Bitplane) with the same quality settings for spot detection for all images (quality threshold 2370, number of voxels threshold 524). Cells were counted as positive if they were located in the granule cell layer and were also positive for NeuN. The area of the granule cell layer in each image was measured in ImageJ, and the density of BrdU/NeuN positive cells was calculated for each image and averaged for all images for each mouse.

Spine quantification ([Figure 5](#fig5){ref-type="fig"}) {#s4-27}
--------------------------------------------------------

All images were 20--40 μm z-stacks with 0.42 z-step taken with a 63x oil immersion objective, and four fields of view were imaged per mouse. Care was taken to ensure minimal saturation (less than 5% of pixels). Secondary and tertiary apical dendrites that were judged to be sufficiently bright, well-separated from adjacent or overlapping dendrites, at least 40 μm long, and extending at an angle from the imaging plane less than 45 degrees were chosen for tracing in Imaris. Each dendrite and all its dendritic protrusions less than 10 μm in length were manually traced using the Filaments function. Data from each dendrite were exported in a text file and imported into Matlab for plotting. For spine density, the Imaris property 'Filament No. Spine Terminal Pts' was used (meaning that branched spines were counted by the number of spine heads rather than attachment points). For spine head volume, the Imaris property 'Spine Part Volume Head' was used. For the classification of filopodial and mushroom spines ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, we used the Imaris properties 'HeadMaxDiameter' and 'NeckMeanDiameter' and classified spines as filopodial if they had maximum head diameter less than 1.5 times the neck mean diameter. This threshold was chosen because it led to a similar ratio of mushroom to filopodial spines in controls as previously observed ([@bib7]).

Electrophysiology ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}) {#s4-28}
-------------------------------------------------------------------------------------

Two experiments with two littermate pairs each (control and PLX-treated) were performed for electrophysiology. Mice were deeply anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) and perfused with ice-cold modified ACSF solution (in mM: 120 choline chloride, 25 glucose, 25 NaHCO3, 2.5 KCl, 0.5 CaCl2, 7 MgSO4, 11.6 ascorbic acid, 3.1 pyruvic acid, 1.25 NaH2PO4). Brains were removed and placed in the same ice-cold modified ACSF. Coronal slices (300 µm thick) of olfactory bulbs were cut using a vibratome (VT1000S; Leica, Germany). Slices were incubated in oxygenated holding solution (in mM: 119 NaCl, 26.2 NaHCO3, 1 NaH2PO4\*H2O, 2.5 KCl, 22 glucose, 1.3 CaCl2, 2.5 MgSO4) at 33°C for at least 30 min before being transferred to oxygenated ACSF (in mM: 119 NaCl, 26.2 NaHCO3, 1 NaH2PO4\*H2O, 2.5 KCl, 22 glucose, 2.5 CaCl2, 1.3 MgSO4). Extra slices were maintained in holding solution at room temperature. Whole-cell recordings (Bessel filtered at 2.2 kHz and acquired at 10 kHz) were performed using patch pipettes filled with internal solution (in mM: 130 cesium gluconate, 5 NaCl, 10 HEPES, 12 phosphocreatine di(tris) salt, 3 Mg\*ATP, 0.2 Na\*GTP, 1 EGTA, 2.0 Na2-ATP, 0.5 Na3-GTP, pH 7.3) using a Multiclamp 700B amplifier (Molecular Devices, Palo Alto, CA) at 36°C. Cells were visualized with dTomato and DIC with custom-built optics on a BX51WI microscope (Olympus Optical, Tokyo, Japan) and recorded with pClamp 10.3 (Molecular Devices). Cell identity was confirmed by the presence of fluorescence material in the patch pipet after membrane rupture and/or cell fill with Alexa Fluor 488, and only cells that had a proximal dendrite that extended from the soma in the direction of the EPL while remaining beneath the surface of the slice (i.e. cells that had dendrites that did not appear to have been cut during slicing) were targeted for patching. Patch pipets had 8--11 MΩ open tip resistance. Series resistance was not compensated. Cells were recorded in continuous 10 s sweeps for five minutes with a test pulse at the beginning of every sweep, which was used to calculate series resistance and holding current in Matlab for initial quality control. sEPSCs were recorded at −70 mV and sIPSCs were recorded at 0 mV. We waited at least one minute after breaking into the cell before beginning recording for sEPSCs and at least 30 s after switching the holding potential for sIPSCs; sEPSCs were always recorded first. Cells were recorded within 8 hr of slicing, and there did not appear to be any relationship between the time of recording and the frequency of synaptic events (data not shown). Experimenters were not blind to experimental group during recording.

Electrophysiology analysis {#s4-29}
--------------------------

Experimenters were blind to experimental group during analysis. Cells with an initial series resistance of \<50 MΩ were used for analysis. Sweeps that deviated from the average series resistance across the first three sweeps by more than 25% or had a holding current of more than 100 pA at −70 mV were excluded. The cell was excluded entirely if less than half of the recording sweeps remained after quality control. For each cell, separate test pulses (−10 mV, 20 ms) with 50 repetitions at 20 kHz were recorded before and after each set of recordings, and these files were used to calculate series resistance (based on the maximum current recorded at the beginning of the pulse), membrane resistance (based on the steady state current during the last 20% of the pulse), and cell capacitance (based on the time constant of an exponential fit between 20% and 80% of the current decay). Reported values in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} and [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} are the means of these parameters from before and after the 5 min of sEPSC recordings. For sEPSCs and sIPSCs, all sweeps were concatenated for each cell (excluding 0.5 s around the test pulse), filtered with a 60 Hz band-stop filter with five harmonics in Matlab, and exported into Mini Analysis v. 6.0.7 (Synaptosoft). sEPSCs were detected with the following parameters: threshold 5, period to search a local minimum 10000, time before a peak to baseline 15000, period to search a decay time 20000, fraction of peak to find a decay time 0.37, period to average a baseline 1000, area threshold 20, number of points to average for peak 1, direction of peak 'negative.' After the initial detection step, 'Scan and detect double peaks' was selected. sIPSCs were detected with the following parameters: threshold 8, period to search a local minimum 10000, time before a peak to baseline 6000, period to search a decay time 20000, fraction of peak to find a decay time 0.37, period to average a baseline 1000, area threshold 80, number of points to average for peak 1, direction of peak 'positive.' In both cases, the detection was manually inspected, and the timepoints spanning any sections of the trace that exhibited increased noise (typically due to fluctuations in seal quality that caused many obviously false positive events) were noted. Event data was exported to a text file and imported into Matlab and noisy sections were excluded before further analysis. Cells that had many noisy sections were excluded. This included 3 control cells and 2 PLX cells for EPSCs and 2 control cells and 4 PLX cells for IPSCs ([Figure 6](#fig6){ref-type="fig"}) as well as 3 control and 3 PLX cells for EPSCs and eight control cells and 9 PLX cells for IPSCs ([Figure 7](#fig7){ref-type="fig"}). Events that were less than 3 ms apart were considered doubly detected and excluded.

Statistical analysis {#s4-30}
--------------------

The number of mice to be used in each experiment was determined in advance, and all data that could be obtained from these mice under the experimental conditions and quality standards described in each section above were included in the analyses. To determine the number of mice for two-photon imaging, we took into account our previous success rate with combined cranial windows/virus injections (about 66%) and aimed to image a similar number of mice as in our previous work (4--7 mice for different experiments, [@bib67]). For electrophysiology, we aimed to obtain data from at least 20 cells per group from 3 to 4 mice, consistent with other electrophysiological investigations in the field that were able to reveal effects of various manipulations ([@bib47]; [@bib51]). Littermates were randomly allocated into control or PLX-treated groups for all experiments. Raw data are shown in every figure, in the form of a scatterplot overlaid on a bar graph when N \< 40 or as a cumulative distribution otherwise. Non-parametric statistical tests were used for all comparisons, so no assumption of normality of data was made. Details for each statistical test can be found in the corresponding figure legend, and the rationale behind each is described here. The two-tailed Wilcoxon rank sum test was used to compare the medians of all unpaired non-normal distributions and correspondingly, the medians are plotted with bars in the figures. A one-tailed permutation test was used to test whether means in the real data were significantly higher than those in offset imaging data in [Figure 1](#fig1){ref-type="fig"}. A two-tailed permutation test was used to test for differences in principal components for the analysis of response time courses in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} (details in section above 'Two-photon imaging, Temporal dynamics'). The hierarchical bootstrap ([@bib10]; [@bib58]) was used to compare groups in the case of hierarchical datasets (details below in section 'Hierarchical bootstrap'). The statistical test and p value for each test is found in the legend corresponding to each figure letter. All n values for each statistical test can be found at the end of each figure legend. In the text, we report mean ± SEM for datasets where means were compared or median (interquartile range) for datasets where medians were compared. For comparisons with hierarchical bootstrap, we report sampling distribution mean ±sampling distribution standard deviation.

Hierarchical bootstrap {#s4-31}
----------------------

Sampling was performed 1000 times for each dataset as described ([@bib58]). Specifically, a sample was taken with replacement across the units of the upper level. For example, in the two-photon imaging data, a sample was taken of the individual mice that were imaged (the sample size was equal to the number of mice). Next, a sample was taken with replacement across the lower level, in this case the dendrites that were imaged. We chose to sample an equal number of dendrites from each mouse, regardless of the original number of dendrites imaged, to ensure that each animal would be represented equally (since the number of dendrites originally imaged for each animal was related to experimental considerations such as the density of viral labeling in each animal). For this level, we chose a sample size (100 dendrites) slightly larger than the largest sample per unit in the original data to ensure a representative sample would be obtained from each mouse. We then report the mean and the standard error of the bootstrapped parameter (either mean, median, or proportion, which is stated in each case) across the 1000 samples. We calculate a p value directly, which represents the probability that the parameter for the control group is greater than that for the PLX-treated group (for cases where the parameter for the PLX-treated group is significantly greater, such as the proportion of dendrites that were unresponsive in the imaging data, we report 1 -- p to avoid confusion with standard p values). The same procedure was performed to analyze datasets for spine morphology (upper level = dendrites, lower level = spines, sample size = 100 spines) and electrophysiology (upper level = cells, lower level = EPSCs or IPSCs, sample size = 5000 EPSCs or IPSCs).
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Thank you for submitting your article \"Microglia are necessary for normal functional development of adult-born neurons in the olfactory bulb\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Gary Westbrook as the Senior and Reviewing Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Amanda Sierra (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Senior Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers were interested in the topic and acknowledged the sophisticated approach to the issue of microglial-synaptic interactions. In particular the set of analyses were thorough and reasonable given the results. However, we were somewhat disappointed by the overall lack of clear mechanism (either tested or hypothesized) about what the microglia are actually doing in the OB, and with respect to abGC maturation/integration. The key points discussed between reviewers are included here, but the full original reviews are at the end of this letter. We urge the authors to fully address the concerns raised as we expect that a revised manuscript would require an additional round of review given the extent of the comments.

Essential revisions:

1\) The authors must acknowledge that depleting microglia may have unintended side effects (including inflammation) and that many microglial functions (beyond spine surveillance) will be altered.

2\) Please better validate the method used to quantify spine surveillance.

3\) The dendritic segments used for quantitation need to be specified and with a sufficient sample size to allow robust interpretation.

4\) Please explain the relationship of dendritic Ca^2+^ correlates with spine Ca^2+^ for these experiments.

5\) Perhaps most importantly, a mechanistic explanation of how microglial surveillance leads to increase spine response to odors is needed.

Reviewer \#1:

The manuscript by Wallace et al. applied sophisticated in vivo 2-p imaging system to demonstrate a critical role of microglia in regulating development of adult-born neurons presumably by interacting with mushroom spines. Importantly, they showed that microglia ablation reduces odor responses of the adult-born neurons but had no effect on mature neurons, which correlates with reduced amplitude of EPSCs and reduced spine volume in adult-born neurons. In general, the experiments are well-designed and properly performed. The data generally support the conclusion. The Discussion section is particularly impressive, as the authors have extensively discussed potential caveats and future directions. Overall, this manuscript is appropriate for publication in *eLife* pending addressing the following points.

Major points:

1\) For spine analysis, the author claimed they picked 1-5 apical dendrites, but it is unclear where those dendritic segments come from. For instance, the spine density maybe different in proximal versus distal dendritic regions. To be consistent, authors should pick the same number of dendritic segments at similar dendritic locations. Furthermore, the number of adult-born neurons they have for spine analysis is considered low. More cells are required for analysis.

2\) Authors studied the interaction between microglia processes and dendritic spines of the adult-born neurons. However, they performed Ca^2+^ imaging in dendrites when multiple distinct odors were introduced. It is unclear how dendritic Ca^2+^ signal correlates with spine Ca^2+^ signals upon odor administration.

3\) Authors consider 5-6 week old neurons as adult-born neurons, and 3 month old neurons as mature neurons. The assumption is that they represent different stages of maturation. However, it is unclear whether the spine phenotype is different between 5-6 week old and 3 month old neurons. Specifically, how different the quantity and quality of the mushroom spines in 5-6 week and 3 month old neurons? Some basic quantification on the spine phenotype from the two time points need to be provided to support the rationale of choosing these two time points.

Reviewer \#2:

Wallace et al. performed series of two photon imaging studies of microglial interactions with developing and mature adult born granule cells (abGCs) in the olfactory bulb. Their findings indicate that microglial processes preferentially interact with abGC spines, and when pharmacologically ablated, leads to decreased odor responsivity and amplitude of excitatory input onto abGCs. Overall, this study presents straightforward evidence that microglia in the olfactory bulb influence responsivity of adult-born granule cells to odors. Specifically, a strength of this study is their use of GCaMP imaging from abGC dendrites in vivo, which shows that the amplitudes of abGC responses to odors are selectively reduced when microglia are ablated during abGC development. The authors present this as a mechanism by which microglial ablation may lead an increase in principle cell odor responses. While the imaging of odor responses in abGC dendrites after microglial ablation is novel and compelling, the supporting evidence regarding microglial interactions with abGC spines and the functional significance (electrophysiology) raise some questions and concerns.

-- The impact of this study would be greatly enhanced by some mechanistic explanation for how microglial contact with mushroom spines leads to an increased response to odors. The authors briefly speculate about pruning and stabilization, but it seems like it is well-within the capabilities of the authors to directly test the pruning hypotheses. Or is this developmental stalling? On the other hand, the impact would also be enhanced by demonstrating a behavioral phenotype after microglial ablation. For example, the authors speculate at the end of the Discussion that \"...microglial regulation of (abGC) development may contribute to ongoing plasticity in the olfactory system.\" This could certainly be tested similarly as in the papers cited as supporting evidence.

-- Although many appropriate analyses were performed, in general the results show relatively small effects, and correlations at times come across a bit overinterpreted. For example, the effect observed regarding microglial interactions with mushroom spines seems trivially small considering the weight that is put on it throughout the paper. Can the differences in average interaction time and number of interactions alone explain the larger effect on microglial ablation on abGC odor responses? The same criticism applies to the interpretation of the spine head volume after ablation and altered mEPSC amplitudes. Is it not also likely that effects of microglial ablation on other cell types in the OB (or throughout the brain) lead to changes in abGC recruitment?

-- Did the authors perform statistics on all the CD plots in Figure 1? Are none significantly different? This applies to all CD plots where significance is not noted throughout the paper.

-- Figure 7---figure supplement 1B directly contradicts the authors\' claim that microglia ablation after abGC maturation does not affect their synaptic input. In fact, this is one of the more compelling differences seen in the electrophysiological recording data. It seems to also directly contradict Figure 7C, where the only difference is that one shows median mEPSC frequency by cell (Figure 7C) and one shows mean mEPSC frequency (Figure 7---figure supplement 1B). It would be helpful to see a more in-depth characterization of mature abGC and resident GC inputs after microglial ablation, especially given the open-ended nature of the discussion eluding to the possibility that the observed trends may indeed point to alterations in mature cells too.

-- It appears that the heads of filopodial spines would be harder to define, and ROIs would be more likely to contain necks. Given the small effect seen in 1e, is it possible that any effect on non-mushroom spines is masked by the inclusion of dendrite and spine shafts?

-- If similar colocalization analysis was performed on the entire visible abGC (including spines and dendrites together) is there a preferential interaction of microglia with whole abGC dendrites (compared to offset data)?

-- The in vivo imaging data compares responses in populations of dendrites imaged from a small number of animals. The small number of animals is understandable given the nature of the experimentation, but nested statistics should be used considering that many data points are collected from the same animals (and even cells) within the same fields of view.

-- The authors state that abGCs initially show broader tuning to odors that become refined over time and during development. It is a bit difficult to completely reconcile and/or understand this statement with respect to the accompanying data given the \"sparser\" responses observed with microglia ablation. Do the authors suggest the affected abGCs are more mature, stalled in development, selectively pruned, or just altered? These observations don\'t seem to fit with any \"tuning\" argument. In fact, other studies have reported broadening of tuning in both abGCs and developing cortical interneurons with maturation.

-- To point above, and given the lack of mechanistic details presented here, it would be appreciated for the authors to at least provide some deeper insight and/or speculation within the discussion of what is actually happening with microglia ablation. Is this developmental stalling, failure for synaptic maintenance, selective survival, unchecked (and selective) pruning of spine subsets? As is, the data do not fully support a clear interpretation.

Reviewer \#3:

The manuscript \"Microglia are necessary for the normal functional development of adult-born neurons in the olfactory bulb\" by Wallace et al., addresses a hot topic in neuroscience (the role of microglia in synaptic connectivity) using as a model adult neurogenesis in the OB. The topic is novel, the experimental design is sound, and the data supports the conclusions. There are a few issues that should be addressed prior to publication, mostly to reach non-specialized audiences.

Major issues:

1\) My major criticism is on the method used to address the role of microglia, i.e., microglial ablation.

In the first place, as the authors succinctly mention in the Discussion, ablation has been associated to the development of inflammatory responses (in some paradigms, it even leads to a \"cytokine storm\"). The authors should clearly define the inflammatory conditions in their model of ablation in the OB (which, to the best of my knowledge, has not been defined yet).

In addition, dead microglia do not just \"vanish\" -- surely, clearing the microglia debris may indirectly affect their results and this should at least be acknowledged in the methodological consideration section.

Finally, the authors seem to imply that ablating microglia solely affects their surveillance of mushroom spines and that thus this must be the only mechanism by which microglia acts on developing newborn neurons. The authors should discuss alternative mechanisms for the observed effect on the functional responses of the newborn neurons.

2\) The method used to analyze the interaction between microglia and spines is rather obscure and does not seem to have been validated before, as no paper is cited either in the Results or the Materials and methods section. If it is not based on previously published methods, the authors must validate it in the context of this paper. To validate their method, the authors should test it with well known co-localizating objects and then test it with the microglia-spine co-localization.

My major concern is that the interaction of microglia with the spines is compared to an Offset image that is calculated by horizontally translating the image stack by half of the total pixels (subsection "Analysis of microglia-spine interactions"). However, using a single Offset (instead of an iteration of Offsets) may lead to strong biases when comparing with the actual data. An example of this potential issue is that the Offset for mushroom spines is 34% whereas is 24.6% for filopodial spines (subsection "Microglia preferentially interact with mushroom spines on abGCs" second paragraph). This difference could be resulting from different densities and relative sizes of the two types of spines; or to the fact that the Offset is not representative of all the possible Offsets.

A more proper control would be in fact to iterate small translations (pixel by pixel) or even rotations (degree be degree) and obtain a probability distribution of Offsets, which then could be compared with the actual data.

Furthermore, in data shown in Figure 1D, the statistical effect seems to be related to an outlier in the real data, not to an actual difference of distribution.

3\) The authors only briefly mention a similar paper published in 2017 in *eLife* on microglial ablation and OB neurogenesis (Reshef et al., The role of microglia and their CX3CR1 signaling in adult neurogenesis in the olfactory bulb). To enhance the perception of novelty the authors should put more effort into clearly discriminating what has been done vs what is learned in this paper (Introduction, paragraph four).

4\) The text is rather arid at times, particularly when describing results using non-conventional techniques, as the authors seem to assume all readers will be fully experts in their methodology.

For instance, in the sentence \"To quantify whether microglia preferentially interact with dendritic spines (defined as colocalization of a microglial process with a spine head, meaning the two are within the diffraction limit of our microscope) on abGCs compared to encountering them by chance during the course of continuous motility\" (subsection "Microglia preferentially interact with mushroom spines on abGCs") the reference to the diffraction limit of the microscope is really puzzling.

Similarly, \"lifetime sparseness\" is not explained (subsection "Odor responses are reduced in abGCs that mature in the absence of microglia" paragraph two).

Principal component analysis is not explained at all (subsection "Odor responses are reduced in abGCs that mature in the absence of microglia" paragraph three) -- which variables were used? (the responses to all 15 odors?).

The authors also state that they applied an \"event detection analysis\" (subsection "Odor responses are reduced in abGCs that mature in the absence of microglia" paragraph three), which is not explained whatsoever.

5\) Some figures are difficult to read.

Figure 1: the parameter measured in each of D-L figures is at the bottom of each pair, and is in small size. So when reading figure 1D one has, in fact, to go to the bottom of Figure 1I to figure out what parameter is actually shown.

Figure 2: odors should be either labeled or numbered (and referenced with names in the figure legend). There is a reference to Table 1 but this reviewer has not been able to find it.

Figure 3---figure supplement 1 shows the same odor and odor mean traces as Figure 3A. Both figures should be combined. In addition, the traces seem to lack asterisks denoting statistical significance.

Figure 3---figure supplement 2 is extremely puzzling. What do X and Y-axes represent in A and B? the eigenvalues of the PCs? The authors should show the 3D plot PC 1 vs PC 2 vs PC 3 showing whether anesthetized and awake mice group separately.

6\) In addition to the number of odors generating responses in anesthetized vs awake mice (Figure 2---figure supplement 2 vs Figure 3A) there seems to be also a quality effect: not the same odors generate responses. The authors should comment on this issue.

7\) The authors should check an efficient microglial ablation in the \"after development\" experiment (Figure 4). They should also speculate why developing neurons seem more susceptible than mature neurons in their regulation by microglia.

8\) The authors conclude that \"In the absence of microglia, these spines have reduced volume, and this corresponds to weaker excitatory synapses.\" The second part of the sentence (whether synapses are weaker in the absence of microglia) has not been directly tested in the paper. The authors should either state that they are speculating, or test it directly.

10.7554/eLife.50531.sa2

Author response

> Essential revisions:
>
> 1\) The authors must acknowledge that depleting microglia may have unintended side effects (including inflammation) and that many microglial functions (beyond spine surveillance) will be altered.

To address this important point, we have added Figure 2---figure supplement 3 which shows that the number of GFAP+ cells in the OB does not change after PLX ablation, supporting previous work (Elmore et al., 2014 and Reshef et al., 2017) that showed that PLX ablation, in contrast to diphtheria toxin-mediated ablation (Bruttger et al., 2015), does not cause widespread inflammation characterized by large increases in the number of GFAP+ astrocytes and a cytokine storm. However, we acknowledge that this does not preclude other undetectable effects on the inflammatory environment, and we have expanded our discussion on this point (in the Discussion section, Methodological Considerations). We have also added to our discussion of possible alterations in microglial function beyond spine surveillance (Discussion, Microglia-neuron interactions in the adult brain) and modified the title of the paper to more accurately represent our results.

> 2\) Please better validate the method used to quantify spine surveillance.

We appreciate the feedback on this point, and have significantly improved our method for analyzing the two photon imaging data on microglia-abGC interactions as the reviewer suggested. Instead of using a single image-offset control on the imaging data, we now perform a series of offsets and construct probability distributions for the measured parameters. The reanalyzed data is shown in Figure 1 and largely supports our original analysis, confirming the increased number of interactions with mushroom spines.

> 3\) The dendritic segments used for quantitation need to be specified and with a sufficient sample size to allow robust interpretation.

We have specified that spines were quantified on secondary and tertiary abGC apical dendrites in the EPL (Results, Synapse development in abGCs that mature in the absence of microglia and Materials and methods, Confocal imaging and quantification, Spine quantification and box in the diagram in Figure 5A). In addition, we increased our sample size for this experiment by tracing dendrites from additional cells. The extended data set supports our original conclusions, with the differences in spine density now significant. We have also added Figure 5---figure supplement 1 to explore the differences in spine density and morphology in control vs. PLX-treated abGCs in more detail.

> 4\) Please explain the relationship of dendritic Ca^2+^ correlates with spine Ca^2+^ for these experiments.

We have clarified this relationship and our choice to measure dendritic Ca^2+^ in abGCs (Results, Odor responses are reduced in abGCs that mature in the absence of microglia and Discussion, AbGCs in the olfactory circuit). We explain further here: Single spine Ca^2+^ transients have not been systematically observed in vivo in granule cells, and the relationship between dendritic and spine calcium and the functional significance of possible compartmentalization has been investigated in slice preparations but not in vivo in these cells. Therefore, we chose to record dendritic calcium events which likely represent dendritic calcium spikes or global calcium events accompanying somatic action potentials that result from simultaneous activation of many feedforward and feedback synapses, which are the most well-characterized patterns of activity in vivo.

> 5\) Perhaps most importantly, a mechanistic explanation of how microglial surveillance leads to increase spine response to odors is needed.

We interpret this point as a request to explain in the text how microglial surveillance may lead to altered functional response of abGCs, rather than a request to perform additional mechanism-seeking experiments (which are difficult and open-ended). We have expanded our discussion on this point ("AbGCs in the olfactory circuit" and "Microglia-neuron interactions in the adult brain") and added Figure 8 to more completely summarize our results and explain our model.

> Reviewer \#1:
>
> \[...\]
>
> 1\) For spine analysis, the author claimed they picked 1-5 apical dendrites, but it is unclear where those dendritic segments come from. For instance, the spine density maybe different in proximal versus distal dendritic regions. To be consistent, authors should pick the same number of dendritic segments at similar dendritic locations. Furthermore, the number of adult-born neurons they have for spine analysis is considered low. More cells are required for analysis.

We agree with the reviewer. We have now specified that spines were quantified on secondary and tertiary abGC apical dendrites in the EPL (Results, "Synapse development in abGCs that mature in the absence of microglia" and Materials and methods, "Confocal imaging and quantification", "Spine quantification" and Figure 5A). In addition, we increased our sample size for this experiment by tracing dendrites from additional cells. The extended data set supports our original conclusions, with the differences in spine density now significant. We have also added Figure 5---figure supplement 1 to explore the differences in spine density and morphology in control vs. PLX-treated abGCs in more detail.

> 2\) Authors studied the interaction between microglia processes and dendritic spines of the adult-born neurons. However, they performed Ca^2+^ imaging in dendrites when multiple distinct odors were introduced. It is unclear how dendritic Ca^2+^ signal correlates with spine Ca^2+^ signals upon odor administration.

We have clarified this relationship and our choice to measure dendritic Ca^2+^ in abGCs (Results, "Odor responses are reduced in abGCs that mature in the absence of microglia" and Discussion, "AbGCs in the olfactory circuit"). We explain further here: Single spine Ca^2+^ transients have not been systematically observed in vivo in granule cells, and the relationship between dendritic and spine calcium and the functional significance of possible compartmentalization has been investigated in slice preparations but not in vivo in these cells. Therefore, we chose to record dendritic calcium events which likely represent dendritic calcium spikes or global calcium events accompanying somatic action potentials that result from simultaneous activation of many feedforward and feedback synapses, which are the most well-characterized patterns of activity in vivo.

> 3\) Authors consider 5-6 week old neurons as adult-born neurons, and 3 month old neurons as mature neurons. The assumption is that they represent different stages of maturation. However, it is unclear whether the spine phenotype is different between 5-6 week old and 3 month old neurons. Specifically, how different the quantity and quality of the mushroom spines in 5-6 week and 3 month old neurons? Some basic quantification on the spine phenotype from the two time points need to be provided to support the rationale of choosing these two time points.

We see the point of confusion raised by the reviewer and have improved the clarity in our text. We do not intend to perform a direct comparison between 5-6 weeks old vs. 3 month old abGCs. We chose 5-6 week old abGCs as a relatively "mature" timepoint (based on our previous in vivo imaging data in Wallace et al., 2017) at which we might expect to see the outcome of differences occurring through development with PLX ablation. We chose the 3 month-old stage as a timepoint at which we could be sure maturation would be completed to test the effect of PLX ablation after development. However, we expect that the exact timepoint would not matter because we previously showed that there was no difference in dendritic calcium responses between mature abGCs (5-6 weeks old) and "resident" GCs that were 2-3 months old at the time of imaging (Wallace et al., 2018, Supplementary Figure 5). We have modified the wording (Results, "Microglia ablation after development has no effect on odor responses") to clarify this.

> Reviewer \#2:
>
> \[...\]
>
> -- The impact of this study would be greatly enhanced by some mechanistic explanation for how microglial contact with mushroom spines leads to an increased response to odors. The authors briefly speculate about pruning and stabilization, but it seems like it is well-within the capabilities of the authors to directly test the pruning hypotheses. Or is this developmental stalling?

We agree with the reviewer that it is important to investigate possible mechanistic explanations. We did in fact test one possible mechanism relating to microglia-neuron interactions, complement C1q-mediated synaptic pruning ([Author response image 1](#respfig1){ref-type="fig"}). We are happy to include these data in the paper if the reviewer and editor prefer. However, ruling out one pathway does not preclude the possibility of pruning occurring in this system. Unfortunately, it is more difficult to test pruning here than it might seem at first glance -- unlike during early development, when entire brain regions experience waves of pruning during defined timepoints, a very small percentage of the total number of granule cells would be at this stage at any given time. Furthermore, most of our (Stevens) lab's previous work points to developmental microglia-mediated pruning occurring on the pre- rather than post-synaptic side, and there is no straightforward way to selectively label and distinguish the inputs to adult-born granule cells (mitral cells and cortical feedback would be expected to synapse onto both adult-born and pre-existing granule cells). Therefore, we feel that addressing mechanisms of pruning would require a large number of experiments, well beyond the scope the present study.

![Spine density and volume are unaffected in C1qKO mice.\
(**a**) Experimental timeline for spine quantification in wild type versus C1qKO mice. Lentivirus was injected into the RMS to label abGCs. Spine numbers and morphology were quantified 4 weeks later. (**b**) Sample image showing sections of apical dendrites from an abGC in a control mouse (top) and a C1qKO mouse (below). (**c**) Spine density averaged in apical dendrites of abGCs. (**d**) Cumulative distribution showing the volume of all spines analyzed. Inset, head volume averaged across all spines in each cell. Bars indicate medians across cells (circles). n = 1215 spines from 26 abGCs from 3 wild type mice and n = 1262 spines from 27 abGCs from 3 C1qKO mice.](elife-50531-resp-fig1){#respfig1}

> On the other hand, the impact would also be enhanced by demonstrating a behavioral phenotype after microglial ablation. For example, the authors speculate at the end of the Discussion that \"...microglial regulation of \[abGC\] development may contribute to ongoing plasticity in the olfactory system.\" This could certainly be tested similarly as in the papers cited as supporting evidence.

We did contemplate testing whether there is a behavioral effect of microglia ablation. However, we opted not to perform these experiments because we felt that the results would be difficult to interpret. Any effect that we might find could not be unambiguously attributed to deficits in abGCs in the olfactory bulb because microglia ablation in our experiments is brain-wide, and it is likely that many olfactory regions are also necessary for the types of olfactory tasks that have been shown to require abGCs. Currently we do not have a way to ablate or manipulate microglia in the olfactory bulb or any specific brain region during a defined time window in adult animals.

> -- Although many appropriate analyses were performed, in general the results show relatively small effects, and correlations at times come across a bit overinterpreted. For example, the effect observed regarding microglial interactions with mushroom spines seems trivially small considering the weight that is put on it throughout the paper. Can the differences in average interaction time and number of interactions alone explain the larger effect on microglial ablation on abGC odor responses? The same criticism applies to the interpretation of the spine head volume after ablation and altered mEPSC amplitudes. Is it not also likely that effects of microglial ablation on other cell types in the OB (or throughout the brain) lead to changes in abGC recruitment?

We agree that the effects on spine head volume and sEPSC amplitude are small, but we argue that changes in calcium responses could easily be larger because dendritic calcium transients are nonlinear outcomes of simultaneous activation of many synapses. We have discussed this further (Discussion, "AbGCs in the olfactory circuit"). We also agree that microglial interactions with spines are only one aspect of microglial function that may be altered when microglia are ablated and we discuss this further in our manuscript (Discussion, "AbGCs in the olfactory circuit" and Discussion, "Microglia-neuron interactions in the adult brain").

> -- Did the authors perform statistics on all the CD plots in Figure 1? Are none significantly different? This applies to all CD plots where significance is not noted throughout the paper.

We modified the analysis for Figure 1 according to Reviewer 3's comments (see response to essential point 2) so this figure no longer shows CD plots.

In general, in most cases we originally showed CD plots to show the cumulative distribution of an entire dataset (for example, all EPSCs from all cells), in the spirit of showing raw data rather than only summary statistics. However, we felt that it would be misleading to perform statistics on these plots (using a Kolmogorov-Smirnov test, example) because the data points are not independent (for example, there are hundreds of sEPSCs recorded from each cell). To deal with this issue, we now use the hierarchical bootstrap (Saravanan et al., 2019) to perform hypothesis testing on these types of hierarchical datasets throughout the paper, in cases where multiple data points are measured from each cell. As discussed in Saravanan et al., 2019, this method is more appropriate for hierarchical datasets (in terms of preserving statistical power and avoiding elevating the false positive rate) than either comparing cumulative distributions of all data points directly or comparing data summarized per unit (for example, taking the mean across each cell and comparing these between groups), which was our original approach. The modified analysis did not change the previous conclusions.

> -- Figure 7---figure supplement 1B directly contradicts the authors\' claim that microglia ablation after abGC maturation does not affect their synaptic input. In fact, this is one of the more compelling differences seen in the electrophysiological recording data. It seems to also directly contradict Figure 7C, where the only difference is that one shows median mEPSC frequency by cell (Figure 7C) and one shows mean mEPSC frequency (Figure 7---figure supplement 1B). It would be helpful to see a more in-depth characterization of mature abGC and resident GC inputs after microglial ablation, especially given the open-ended nature of the discussion eluding to the possibility that the observed trends may indeed point to alterations in mature cells too.

We agree that this was unclear. The difference between the original Figure 7C and Figure 7---figure supplement 1B was that Figure 7C shows frequency calculated as inter-event frequency (so there will be one data point for each event) while Figure 7---figure supplement 1B showed average frequency across the entire recording period (total \# of events divided by total time, i.e. one value for each cell). Related to the point above about the analysis of hierarchical datasets (Saravanan et al., 2019), we have removed Figure 7---figure supplement 1 and instead reanalyzed the data in Figure 7C with the hierarchical bootstrap. This new analysis shows that the same trend is present regardless of how frequency is calculated in this dataset (Figure 7C---the mean frequency is higher for PLX-treated cells), although it does not reach the threshold for statistical significance. We have reflected on this further in the Discussion, Timing of microglia ablation.

> -- It appears that the heads of filopodial spines would be harder to define, and ROIs would be more likely to contain necks. Given the small effect seen in 1e, is it possible that any effect on non-mushroom spines is masked by the inclusion of dendrite and spine shafts?

We drew ROIs on filopodial spines to be approximately circular with diameter equal to the width of the spine head, so it is unlikely that a substantial portion of the shaft was included, and ROIs did not include any portion of the parent dendrite. Without performing electron microscopy reconstructions, we can only do our best to estimate the location of the postsynaptic density for both types of spines.

> -- If similar colocalization analysis was performed on the entire visible abGC (including spines and dendrites together) is there a preferential interaction of microglia with whole abGC dendrites (compared to offset data)?

We did not perform this analysis because it is unclear to us how changes in microglial interaction with dendrites rather than synapses could be interpreted as this has not yet been explored in the field.

*-- The* in vivo *imaging data compares responses in populations of dendrites imaged from a small number of animals. The small number of animals is understandable given the nature of the experimentation, but nested statistics should be used considering that many data points are collected from the same animals (and even cells) within the same fields of view.*

We agree that this is an important statistical problem that is often not adequately addressed in the field, and we sincerely thank the reviewer for pointing this out. This motivated us to apply the hierarchical bootstrap method to our data, as discussed above.

> -- The authors state that abGCs initially show broader tuning to odors that become refined over time and during development. It is a bit difficult to completely reconcile and/or understand this statement with respect to the accompanying data given the \"sparser\" responses observed with microglia ablation. Do the authors suggest the affected abGCs are more mature, stalled in development, selectively pruned, or just altered? These observations don\'t seem to fit with any \"tuning\" argument. In fact, other studies have reported broadening of tuning in both abGCs and developing cortical interneurons with maturation.

We agree with the reviewer that it is difficult to interpret the sparser odor responses in PLX-treated mice in light of our previous data showing the mature abGCs have sparser responses than young abGCs, primarily because the mechanisms that underlie normal developmental maturation of odor responses in these cells are still under active investigation. We have expanded our discussion of this point in the Discussion section, "AbGCs in the olfactory circuit". In addition, we added Figure 8 to propose a model that integrates the results of the current study with our previous study (Wallace et al., 2017) and puts these findings in the context of other studies of abGC development. In short, we suggest that microglia ablation affects some aspects of abGC development (maturation and possibly selective reorganization of excitatory inputs) but not others (decrease in excitability and input resistance), leading to the phenotype we observe.

We note that it is difficult to compare maturation of abGCs with cortical interneurons, given their vastly different connectivity patterns in their respective circuits (for example PV interneurons are densely interconnected with excitatory neurons in both cortex and OB, but granule cells are much more sparsely connected than PV cells in the OB (Kato et al., 2013)).

> -- To point above, and given the lack of mechanistic details presented here, it would be appreciated for the authors to at least provide some deeper insight and/or speculation within the discussion of what is actually happening with microglia ablation. Is this developmental stalling, failure for synaptic maintenance, selective survival, unchecked (and selective) pruning of spine subsets? As is, the data do not fully support a clear interpretation.

We appreciate this comment, and it has motivated us to clarify our hypotheses about what is happening in this system by adding Figure 8, which summarizes our findings in the context of a potential model for how microglia might be acting on abGCs. As explained in our response to the previous point as well as in the Discussion section, "AbGCs in the olfactory circuit", we suggest that microglia ablation affects some aspects of abGC development (maturation and possibly selective reorganization of excitatory inputs) but not others (decrease in excitability and input resistance), leading to the phenotype we observe.

> Reviewer \#3:
>
> \[...\]
>
> 1\) My major criticism is on the method used to address the role of microglia, i.e., microglial ablation.
>
> In the first place, as the authors succinctly mention in the Discussion, ablation has been associated to the development of inflammatory responses (in some paradigms, it even leads to a \"cytokine storm\"). The authors should clearly define the inflammatory conditions in their model of ablation in the OB (which, to the best of my knowledge, has not been defined yet).
>
> In addition, dead microglia do not just \"vanish\" -- surely, clearing the microglia debris may indirectly affect their results and this should at least be acknowledged in the methodological consideration section.

To address this important point, we have added Figure 2---figure supplement 3 which shows that the number of GFAP+ cells in the OB does not change after PLX ablation, supporting previous work (Elmore et al., 2014 and Reshef et al., 2017) that showed that PLX ablation, in contrast to diphtheria toxin-mediated ablation (Bruttger et al., 2015), does not cause widespread inflammation characterized by large increases in the number of GFAP+ astrocytes and a cytokine storm. However, we acknowledge that this does not preclude other undetectable effects on the inflammatory environment, and we have expanded our discussion on this point (in the section Discussion, "Methodological considerations").

> Finally, the authors seem to imply that ablating microglia solely affects their surveillance of mushroom spines and that thus this must be the only mechanism by which microglia acts on developing newborn neurons. The authors should discuss alternative mechanisms for the observed effect on the functional responses of the newborn neurons.

We have added to our discussion of possible alterations in microglial function beyond spine surveillance (Discussion, "Microglia-neuron interactions in the adult brain") and modified the title of the paper to more accurately represent our results.

> 2\) The method used to analyze the interaction between microglia and spines is rather obscure and does not seem to have been validated before, as no paper is cited either in the Results or the Materials and methods section. If it is not based on previously published methods, the authors must validate it in the context of this paper. To validate their method, the authors should test it with well-known co-localizating objects and then test it with the microglia-spine co-localization.
>
> My major concern is that the interaction of microglia with the spines is compared to an Offset image that is calculated by horizontally translating the image stack by half of the total pixels (subsection "Analysis of microglia-spine interactions"). However, using a single Offset (instead of an iteration of Offsets) may lead to strong biases when comparing with the actual data. An example of this potential issue is that the Offset for mushroom spines is 34% whereas is 24.6% for filopodial spines (subsection "Microglia preferentially interact with mushroom spines on abGCs" second paragraph). This difference could be resulting from different densities and relative sizes of the two types of spines; or to the fact that the Offset is not representative of all the possible Offsets.
>
> A more proper control would be in fact to iterate small translations (pixel by pixel) or even rotations (degree be degree) and obtain a probability distribution of Offsets, which then could be compared with the actual data.
>
> Furthermore, in data shown in Figure 1D, the statistical effect seems to be related to an outlier in the real data, not to an actual difference of distribution.

We appreciate the reviewer's detailed assessment of the method and agree with the concern that using a single Offset may not adequately represent a true shuffling of the data. Therefore, we have implemented the method the reviewer has suggested (iterating through many offsets).

Please see response to essential point 2 for further details.

> 3\) The authors only briefly mention a similar paper published in 2017 in eLife on microglial ablation and OB neurogenesis (Reshef et al., The role of microglia and their CX3CR1 signaling in adult neurogenesis in the olfactory bulb). To enhance the perception of novelty the authors should put more effort into clearly discriminating what has been done vs what is learned in this paper (Introduction, paragraph four).

We have expanded our reference to this work both in the Introduction and in the Discussion to clarify that we have analyzed the functional effects of microglia ablation on abGCs, providing a mechanistic explanation for the reduction in mitral cell activity observed in Reshef et al., 2017.

> 4\) The text is rather arid at times, particularly when describing results using non-conventional techniques, as the authors seem to assume all readers will be fully experts in their methodology.
>
> For instance, in the sentence \"To quantify whether microglia preferentially interact with dendritic spines (defined as colocalization of a microglial process with a spine head, meaning the two are within the diffraction limit of our microscope) on abGCs compared to encountering them by chance during the course of continuous motility\" (subsection "Microglia preferentially interact with mushroom spines on abGCs") the reference to the diffraction limit of the microscope is really puzzling.
>
> Similarly, \"lifetime sparseness\" is not explained (subsection "Odor responses are reduced in abGCs that mature in the absence of microglia" paragraph two).
>
> Principal component analysis is not explained at all (subsection "Odor responses are reduced in abGCs that mature in the absence of microglia" paragraph three) -- which variables were used? (the responses to all 15 odors?).
>
> The authors also state that they applied an \"event detection analysis\" (subsection "Odor responses are reduced in abGCs that mature in the absence of microglia" paragraph three), which is not explained whatsoever.

We appreciate the feedback on this point and have endeavoured to clarify the reasoning behind our use of these methods in the main text, with references to the Materials and methods section where appropriate.

> 5\) Some figures are difficult to read.
>
> Figure 1: the parameter measured in each of D-L figures is at the bottom of each pair, and is in small size. So when reading Figure 1D one has, in fact, to go to the bottom of Figure 1I to figure out what parameter is actually shown.

We added labels to each individual panel to improve the readability of Figure 1.

> Figure 2: odors should be either labeled or numbered (and referenced with names in the figure legend). There is a reference to Table 1 but this reviewer has not been able to find it.

Due to the length of some of the chemical names, we opted not to include these in the figure itself. Thank you for alerting us to the omission of the odor list, we have now included Table 1 in the Materials and methods under the section "Odor stimulation".

> Figure 3---figure supplement 1 shows the same odor and odor mean traces as Figure 3A. Both figures should be combined. In addition, the traces seem to lack asterisks denoting statistical significance.

Thank you, we have combined these figures. We did not include asterisks for these traces (similar to Figure 2E) because we did not test differences for individual odors (to avoid issues with multiple comparisons) and rather restricted significance testing to parts B, C, and D. In contrast, we show asterisks in Figure 2D denoting individual example responses above threshold.

> Figure 3---figure supplement 2 is extremely puzzling. What do X and Y-axes represent in A and B? the eigenvalues of the PCs? The authors should show the 3D plot PC 1 vs PC 2 vs PC 3 showing whether anesthetized and awake mice group separately.

Thank you for pointing this out. We have clarified in the legend that the x-axis represents time and the y-axis represents ΔF/F~σ~. We have plotted it this way (as in Wienisch and Murthy, 2016 and Wallace et al., 2017) because a single 3D plot could not show the entire time course. As we have now clarified in the Materials and methods ("In vivoimaging analysis" and "Temporal dynamics"), we then used a permutation test to compare the time courses between control and PLX-treated mice for each condition.

> 6\) In addition to the number of odors generating responses in anesthetized vs awake mice (Figure 2---figure supplement 2 vs Figure 3A) there seems to be also a quality effect: not the same odors generate responses. The authors should comment on this issue.

Previous studies (Kato et al., 2012; Wienisch and Murthy, 2016; Wallace et al., 2017) have described significant reorganization of responses in granule cells in awake vs. anesthetized mice, which was part of the rationale for imaging in both conditions. Specifically, there seems to be a weaker relationship between the number of glomeruli activated by each odor and the number of granule cells activated in awake mice compared to anesthetized mice (Wienisch and Murthy, 2016). We did not comment extensively on this in the paper because we thought it might distract from the difference between control and PLX-treated mice, but we could add more discussion if the reviewer prefers.

> 7\) The authors should check an efficient microglial ablation in the \"after development\" experiment (Figure 4).

This is shown in Figure 2---figure supplement 2D.

> They should also speculate why developing neurons seem more susceptible than mature neurons in their regulation by microglia.

We have discussed this in the Discussion section, "Timing of microglia ablation".

> 8\) The authors conclude that \"In the absence of microglia, these spines have reduced volume, and this corresponds to weaker excitatory synapses.\" The second part of the sentence (whether synapses are weaker in the absence of microglia) has not been directly tested in the paper. The authors should either state that they are speculating, or test it directly.

This conclusion is based on our finding that the amplitude of sEPSCs is reduced with PLX treatment in developing abGCs (Figure 6D).
